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Abstract 
Background 
Obesity and low physical activity (PA) contribute to cancer survivors’ poorer disease and 
outcomes. Guidelines for survivors are (1) remain physically active; (2) high fruit and vegetable 
diet; (3) maintain healthy weight. Despite these recommendations, access to lifestyle programs 
are not integrated into survivorship care. This study evaluated the feasibility of a weight 
management program (WMP) for overweight/obese cancer survivors at the Sydney 
Survivorship Centre. 
Method 
Overweight (BMI ≥25kg/m2) adult patients with localised cancer reviewed at the Survivorship 
Clinic who had completed a 6-week lifestyle intervention, were eligible. The 6 month 
intervention comprised (1) clinic assessment and behaviour counselling consultation; (2) 
supervised exercise sessions (2/week); and (3) dietary sessions (n=12). Outcome measures were 
assessed at 0, 3 and 6 months. Primary outcome was attendance. Secondary outcomes included 
body composition, PA levels, nutritional quality, patient reported outcomes, blood biomarkers, 
and a qualitative interview. 
Results 
All 12 participants were female; median age 56 (range 45-71). Tumour groups represented: 
breast 67%, colorectal 25%, Non-Hodgkin’s Lymphoma 8%. At baseline, 3 participants were 
overweight, 9 were obese (≥30kg/m2), and 9 had >1 comorbidity. Participants attended 97%  
clinics, 71%  exercise, and 81% of dietary sessions.  Post-intervention, mean weight change was 
-4.9kg (range 0.1 to -19.6), 5% initial weight. Waist circumference reduced 3.8cm (range -13.2 
to 4.8), 3% body fat mass reduced and 2% lean body mass increase. Participants improved 
aerobic fitness, maximal strength, and fruit and vegetable intake. No changes in fatigue, quality 
of life, depression, anxiety or stress were reported.  There was no change in blood markers 
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(fasting glucose, IGF-1, cholesterol, C-reactive protein). Program tailoring and support from 
facilitators and co-participants, were enablers of intervention attendance. 
Conclusion 
This study confirms overweight cancer survivors are willing to attend a WMP. The program 
enabled positive changes to weight, body composition, fitness and nutritional quality despite 
impact of stress, anxiety, depression and fatigue. Longer follow up will determine if weight loss 
and healthy lifestyle behaviours are sustained. 
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Background 
Obesity and cancer are two leading global chronic health conditions that are increasing in 
incidence1.  Evidence has established a link between obesity and eleven different types of 
cancer, in addition to obesity being a major risk factor for cardiovascular disease and Type II 
diabetes2. In Australia, 63% of the population are overweight or obese, and 56% are physically 
inactive or 52% do not eat recommended two serves of fruit and 92% do not eat recommend 
serves of vegetables3. These three lifestyle behaviours are not only leading modifiable risk 
factors for cancer development but also contribute to disease burden and poorer disease and 
health-related outcomes4. 
 
It is a common occurrence for people undergoing treatment for cancer, particularly women 
with breast cancer, to experience weight gain. This increase in total body weight is 
accompanied by an increase in central adiposity and a reduction in lean body mass5-7. These 
alterations in body composition, primarily greater body fatness and total body weight have 
been found to be linked with a poorer cancer prognosis and higher risk of cancer recurrence, as 
well as reduced tolerance to cytotoxic agents, worse physical functioning and poorer overall 
quality of life4,8,9. Putative causal mechanisms include increasing circulation of sex hormones, 
insulin resistance, and inflammatory cytokines6. A recent meta-analysis including more than 
200,000 breast cancer survivors showed a 14-29% increased risk of cancer-specific mortality for 
every 5kg/m2 increase in body mass index (BMI)10. Similar figures have also been observed for 
overweight patients with prostate (20% increase in prostate cancer mortality) and early 
observational data for colon cancer11.  
 
Current recommendations regarding physical activity and diet after a cancer diagnosis are 
similar across leading health organisations, and are based on observational data. The World 
Cancer Research Fund/American Institute of Cancer Research (WCRF/AICR)2, American Cancer 
Society (ACS)12, and the National Comprehensive Cancer Network13 advise patients to achieve 
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and maintain a healthy weight, engage in regular physical activity, and have a diet high in 
vegetables, fruit and grains.  
 
Despite these recommendations there is limited access to healthy lifestyle programs in 
Australia as they are not routinely translated into the clinical setting 14. With evidence mounting 
regarding the link between obesity and increased cancer risk and poorer outcomes, and the 
need for weight management interventions7, the American Society of Clinical Oncology (ASCO), 
the largest international oncology organisation, is advocating for policy and systems to address 
these issues, and improve access to lifestyle services for cancer survivors 11. Clinical documents 
have recently been sponsored by ASCO and the American Cancer Society to provide resources 
and rationale for managing obesity15,16. Further research is necessary in large, randomised 
controlled trials testing purposeful weight loss and positive body composition outcomes on 
overall and cancer-specific survival. 
 
In non-cancer populations, effective weight loss interventions involve a three-prong approach: 
1) behavioural counselling; 2) exercise; and 3) caloric restriction healthy eating17. A total body 
weight loss of 5-10% is significant for reducing cardiovascular risk factors, with interventions 
resulting in as little as 3% sustained total body weight reduction showing improvements in 
clinically meaningful cardiovascular outcomes18. It has however been observed that maximum 
body weight reduction following a six month intervention is often followed by a plateau and/or 
gradual regain of weight over time if follow up is not continued19 20. 
 
To add to the systematic review published in 2014 by Reeves et al21, to date there have been 
eleven published randomised controlled trials (RCTs) addressing purposeful weight loss in 
cancer survivors utilising a combined exercise and nutrition intervention with or without an 
incorporated behavioural model. These studies are primarily in breast cancer survivors (91%) 
with sample sizes ranging from 28 – 697 participants. The recently completed ENERGY (Exercise 
and Nutrition to Enhance Recovery and Good Health for You) Trial is the largest RCT to date 
targeting weight change after the completion of primary treatment for early-stage breast 
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cancer survivors with a BMI 25-40kg/m2 22. Participants randomised to the intervention 
received a 2-year group and telephone based program, consisting of 24-48 participant contacts, 
facilitated by a dietitian, psychologist, or exercise physiologist. The study had dietary goal 
deficit of 500-1000 kcal/day, with the aim of gradually building up to 60 minutes of moderate 
intensity exercise daily. The intervention was based on the Social Cognitive Theory framework 
and cognitive behavioural therapy techniques. This was compared to a less intensive 
intervention in which participants received individualised weight loss counselling on two 
occasions only. At 12 months, the intervention group had a mean weight loss of 6% compared 
to 1.5% in the less intensive group (p<0.001) and 3.7% vs. 1.3% (p<0.001) at 24 months.  Waist 
circumference was the only body composition measure reported, with a significant difference 
between groups at 12 months only (mean 97.8 cm vs. 100.4 cm) (p<.004). One other RCT has 
reported two-year follow up results from a weight management intervention for 
postmenopausal breast cancer women (with a BMI ≥24kg/m2), who were receiving letrozole 
(LISA Trial)23. Participants (n=338) were randomised to receive either a telephone-based, 
individualised lifestyle intervention facilitated by a lifestyle coach, compared to receipt of 
healthy lifestyle materials only via mail. At 6 months, the intervention group had a mean weight 
loss of 5.3% compared to 0.7% in the control group (p<0.001) and 3.6% compared to 0.4% 
(p<0.001) at 24 months. Both of the studies discussed above showed the ability for survivors to 
sustain weight loss two years after intervention commencement. The only trial not conducted 
in breast cancer survivors, that had weight change as the primary endpoint, evaluated an 
intervention for endometrial cancer survivors comparing a 6-month nutritional, exercise and 
behavioural modification intervention to usual care (SUCCEED)24. The results of this 
intervention reported significant mean differences in weight change between groups at 6-
months (-4.4kg, p<0.001) and 12-months (-4.6kg, p<0.001). 
 
A search of Australian New Zealand Clinical Trials Registry and clinicaltrials.gov resulted in four 
currently recruiting randomised controlled trials promoting weight loss with a diet and exercise 
intervention. Three are targeted at breast cancer survivors and one at prostate cancer survivors 
[ClinicalTrials.gov Identifier: NCT0262271; NCT02454517; NCT02699983; 
4 
 
ACTRN12612000997853]. Of these trials, one is active in Australia.  The study team are trialling 
a telephone-based intervention for overweight and obese women following treatment for 
breast cancer [ACTRN12612000997853]. The primary outcome is weight loss at 6 (short term), 
12 (end of intervention), and 18 months (post intervention). 
 
Here I aimed to evaluate the feasibility of implementing a 24-month, diet and exercise weight 
management program for overweight and obese cancer survivors attending the Sydney 
Survivorship Centre, outpatient cancer service. This thesis will report on the findings from the 
baseline (0 month), 3-month (mid-intervention) and post-intervention (6-month) assessments 
only. 
Methods 
Study Design 
This study used an experimental pre-post-test, single group design, to evaluate the feasibility of 
a newly developed Weight Management program in overweight and obese Cancer Survivors 
(WeMICS).  
Participants  
Participants for the weight management program (WMP) were recruited from the Sydney 
Survivorship Clinic (SSC) at Concord Cancer Centre, where on their first visit all patients are 
routinely consulted by a medical oncologist or haematologist, cancer nurse specialist, clinical 
psychologist, dietitian and accredited exercise physiologist (AEP). Eligibility for the SSC are adult 
survivors (≥18 years) who have completed primary anti-cancer treatment (including surgery, 
chemotherapy and/or radiotherapy) for a localised solid tumour. Patients can be receiving 
endocrine therapy or trastuzumab. Further eligibility criteria for the WMP included a body mass 
index (BMI) of >25kg/m2, and completing the 6-week Exercise and Nutrition Routine Improving 
Cancer Health (ENRICH) program run by the Cancer Council NSW and the Sydney Survivorship 
Centre. ENRICH is a 2 hour/week exercise and nutrition group-based program based on the 
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Social Cognitive Theory and Chronic Disease Self-Management models which aims to educate 
participants in skill development, personal monitoring, goal setting, problem solving, and 
making sustainable changes25. Patients were excluded from the study if they had: (1) 
recurrence of their cancer, (2) significant pre-existing comorbidities precluding exercise and/or 
change in diet, or (3) insufficient English fluency. The study was approved by the Sydney Local 
Health District Human Research Ethics Committee. All participants provided written informed 
consent and completed the Readiness for Physical Activity Questionnaire (rPAR-Q). 
Intervention 
The WMP was facilitated by an AEP and an oncology dietitian, both with experience providing 
interventions for people with cancer and trained in behaviour change delivery. The intervention 
consisted of three components: (1) clinic assessment and behaviour counselling consultation; 
(2) supervised exercise; and (3) dietary intervention. Behaviour change was additionally 
incorporated into the exercise and dietary sessions based on the Social Cognitive Theory. Catch-
up and additional sessions were allowed. 
Clinic Assessment and Behaviour Counselling Consultation 
Participants were required to attend the clinic on 6 occasions (0, 3, 6, 12, 18 and 24 months). 
Participants were reviewed by the AEP and Oncology Dietitian at each visit. The initial clinic visit 
was two hours (one hour per health professional) in duration, with follow-up clinics one hour 
(30 minutes per health professional), and held in the medical oncology consult rooms. A 
Survivorship Oncologist or Fellow was available for assessment of clinical status and/or review 
of pathology results as required. Body composition, anthropometrical measurements, patient 
reported outcomes (PROs) and fasting blood collection were performed at each visit. 
Behavioural change counselling was provided by both health professionals; it was participant-
centred, and based on the Social Cognitive Theory (SCT). SCT-based theories have been found 
to lead to positive changes for cancer survivors26. Assessment of patient goals, resting blood 
pressure, resting heart rate and weight (kg) were documented as per standard clinical 
procedure (Appendix 7). 
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Supervised Exercise Intervention 
Participants were required to attend two, AEP supervised, 60-minute exercise sessions in the 
Survivorship Gym each week for 6 months (26 weeks). There were five session times available 
each week from which participants could select. Groups were limited to a maximum of five 
people due to space limitations in the gym. All sessions commenced with a 10-minute warm-up 
and finished with a 5-minute cool-down period. All programs were individualised to cater for 
the participant’s ability, any comorbidities and enjoyment. A combination of both moderate-
high intensity aerobic (>75% age-predicted heart rate maximum) and resistance exercises 
(Borg’s rating of perceived exertion [RPE] 12-16) were included. Participants were encouraged 
to monitor and progress their own programs with the AEP available for additional guidance as 
required. Physical activity diaries were encouraged but were not incorporated as a study 
measurement tool.  
Dietary Intervention 
Participants were required to attend one face-to-face, 30-40 minute dietary group session 
weekly for the first 6 weeks. This was facilitated by the oncology dietitian, and consisted of 
practical tips to promote a healthy diet. These sessions continued fortnightly from week 7 to 
12, and then monthly until week 26 (6 months). There were two allocated time slots per week 
for patients to choose from.  Sessions were conducted within the Survivorship Cottage, with full 
access to a kitchen. The aim of the dietary intervention was to improve diet quality and dietary 
habits. The primary focus was on fruit and vegetable intake, reduction in total energy intake 
through reducing unhealthy snack habits, and using healthy cooking methods. At the first visit, 
participants were provided with individualised recommendations on how to modify their total 
energy intake as measured in their pre-intervention 3-day food diary. Participants were 
educated on how to assess their own protein, dairy, fruit and vegetable intake based on the 
recommendations of the Australian Guide to Healthy Eating (AGHE) (Appendix 10), which is 
based on the Australian Dietary Guidelines27. 
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Table 1. Weight management program outline 
 
Component Timing Nature 
Clinic assessment and 
behavioural counselling 
consultation 
0, 3, 6, 12, 18, 24 months  Review with AEP, Dietitian 
 Medical review in addition to usual follow up as required 
 Behavioural change counselling 
 Anthropometrical assessments 
 Clinical assessment  
Supervised exercise session 0-6 months 
2 sessions per week  
 
 Tailored program incorporating both aerobic and resistance training 
 Progress monitoring 
Dietary intervention Week 1-6: Weekly 
Week 7-12: Fortnightly 
Week 13-26: Monthly 
 Self-assessment of dietary intake (food diary)  
 Strategies to encourage healthy eating and barriers to adhere to 
AGHE Guidelines.  
 Fruit and vegetable intake, portion size, snacks and comfort eating 
are the main topics for discussion. 
 Barriers and strategies to overcome the barriers.  
Abbreviations:  
AEP, Accredited Exercise Physiologist; AGHE, Australian Guide to Healthy Eating 
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Outcome measures 
Outcomes measures were assessed at baseline (0 months), mid-intervention (3 months), post-
intervention (6 months) and follow-up (12, 18 and 24 months). Here we report only the first 
three time points. 
 
Patient demographics 
Demographic information including cancer and treatment details, concomitant medications, 
comorbidities and weight history were obtained from the patient’s medical record and 
survivorship care plan. 
 
Primary outcome 
The primary outcome was attendance at the clinic, supervised exercise sessions, and face-to-
face dietary sessions.  This was documented using standardised forms, with reasons for non-
attendance documented and coded. 
 
Secondary outcomes 
Body composition 
Body composition was measured using a single frequency 50 kHz bioelectrical impedance (BIA) 
device (ImpediMed DF 50) performed with single frequency. Skinfold measurements were 
taken at three sites (triceps, subscapular and medial calf) using Harpendon skinfold calipers, 
according to the International Society for the Advancement of Kinanthropometry (ISAK) 
methodology28. Waist, upper arm (relaxed), and calf girths were measured using a non-elastic 
measuring tape to the nearest 0.1cm using the same guidelines. All measurements were 
performed three times and the median score recorded by the same trained assessor with Level 
1 ISAK Anthropometry credentials. Stretched stature was measured using a stadiometer to the 
nearest 0.1cm. Body weight was recorded using electronic scales to the nearest 0.1kg. 
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Physical Activity Levels 
Participants were requested to wear an accelerometer (Actilife v4.1.1) on their right hip for 
seven days prior to commencing the intervention and at completion of the intervention to 
objectively measure PA levels (Appendix 9). Total steps/day, and minutes spent in light, 
moderate and vigorous activity per day were recorded. Data from four valid wear time days 
was required for inclusion in the analysis.  
 
Participants self-reported their activity over the same time periods, and prior to the 3 month 
assessment, using the International Physical Activity Questionnaire Short Form (IPAQ-SF)29. The 
IPAQ-SF is a validated tool assessing self-report PA levels in healthy populations and has been 
used in cancer populations30. This questionnaire categorises responders into three groups 
based on PA across all domains: 1) Inactive: those not meeting criteria for group 2 or 3; 2) 
Minimally active: those meeting recommended PA guidelines of ≥3 days of ≥20 min of vigorous 
activity OR ≥5 days of ≥30 min of moderate intensity activity OR ≥5 days of combination of 
walking, moderate intensity or vigorous intensity achieving ≥600 MET-min/week; and, 3) Health 
enhancing physical activity (HEPA): exceeding recommended guidelines with ≥1.5-2 hours 
moderate intensity activity per day. 
 
Dietary assessment 
At assessment time points, participants were asked to keep a food diary for three consecutive 
days, inclusive of one weekend day. They were taught how to weigh their food and fluid intake 
to record during this period. At a minimum, if a participant did not have access to kitchen 
scales, they were asked to use measuring cups. Dietary intake was measured using a 3-day 
weighed food diary and analysed by the study dietitian using the computer software 
FoodWorks (Version 7.0). Standard recipes were created within FoodWorks for home cooked 
foods, and generic food items were selected if details were unknown (i.e. the brand of food 
products).  
 
Exercise Assessment 
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Handgrip dynamometry (Jamar Digital Plus) was recorded to the nearest 0.1kg. Three handgrip 
measures of the dominant and non-dominant hands were taken and the mean for each hand 
recorded. Aerobic fitness was assessed using a modified Balke protocol performed on a 
treadmill to 85% of the participant’s maximal heart rate or exhaustion. Throughout the test, 
participant’s heart rate, blood pressure and rating of perceived exertion were monitored. After 
each three minute period the speed and/or gradient of the treadmill was increased. Maximal 
leg strength was assessed using a 1-repetition maximum (RM) test on a 75° leg press 
(LifeFitness, Inc.). For participants that were contraindicated for either of these assessments, an 
alternative of a six-minute walk test and/or 30-second chair stand was permitted. 
 
Quality of Life 
Health-related quality of life (QOL) was measured using the 30-item European Organisation for 
Research and Treatment of Cancer (EORTC QLQ-C30), which is validated for assessment of QOL 
in cancer patients. It incorporates five functional scales, a global health QOL scale, and three 
symptom scales. Scores range from 0 to 100 where higher scores represent better health for 
global health and functional domains31. 
 
Depression, anxiety and stress 
Symptoms of depression, anxiety and stress were assessed using the short form Depression, 
Anxiety and Stress Scale (DASS-21). The DASS-21 is designed to measure the negative emotional 
states of these three scales, and is classified as moderate, severe or extremely severe. Distress 
was measured using the National Comprehensive Cancer Network (NCCN) Distress 
Thermometer for Patients32. Scoring is from 0-10 with a score of ≥4 classed as at least moderate 
distress, with referral for further assessment recommended. 
 
Fatigue  
Fatigue was measured using the 13-item Functional Assessment of Chronic Illness Therapy-
Fatigue (FACIT-F) subscale. This scale is a reliable and valid measure of fatigue in people with 
cancer33. Scores range from 0 to 52 with a higher score representing less fatigue. 
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Blood Results 
Fasting blood samples assessed: glucose, lipids, triglycerides, C-reactive protein (CRP), insulin-
like growth factor- 1 (IGF-1) and haemoglobin.  Participants were asked to fast from 10.00 pm 
the preceding night. Samples were collected between 7.30 am and 10.00 am by a registered 
nurse and processed by the central laboratory at Concord Repatriation General Hospital. 
Samples for Ghrelin and peptide YY were processed and stored at -80C for future analyses. An 
additional vial was collected at baseline for future studies and stored at -80C.  
 
Adverse events 
Adverse events as a consequence of the program were recorded and graded using the National 
Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0. 
Treatment-related side effects and/or ongoing toxicities were recorded as per standard clinical 
procedure at each clinic visit. 
 
Program Satisfaction 
Participant satisfaction with the program was measured using an investigator-developed, ten-
item, 5-point Likert Scale (Appendix 12). This was completed one time only at the completion of 
the 6-month intervention assessing knowledge and expertise of staff, enjoyment, and 
suggestions to improve the quality of the program. 
 
Qualitative Data 
Recorded, semi-structured telephone interviews were completed after the 6 month 
intervention (Appendix 13). Interviews were conducted by researchers from the Survivorship 
Research Group, not otherwise involved in this study. The interviews were transcribed verbatim 
and themes were derived from the data and coded by the study team using a framework 
analysis approach. 
 
Statistical Analysis 
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All data were stored within the REDCapTM database.  All data were analysed using SPSS (version 
21). Frequency was used to report attendance and descriptive statistics are reported as means 
(range) and standard deviations. Changes in outcome variables from baseline (0 month) to 
post-intervention (6-months) were measured using paired samples t-test, with 95% confidence 
interval (CI). Measures of significance are not reported due to the small sample size. The 
sample size was determined on the basis of feasibility. The study is ongoing and final sample 
size will be 20 patients. 
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Results 
 
Recruitment 
Between October 2014 and October 2015, 18 overweight/obese patients who had attended the 
Survivorship Clinic and completed the Concord ENRICH program were approached to 
participate in the weight management program. Six patients declined participation due to 
reasons listed in Figure 1. In total, 12 survivors (67%) consented to participate in the study. 
  
Figure 1. Participant flow diagram of enrolment, exclusions and assessment completion 
(September 2014 – December 2015) 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Approached (n=18) 
Baseline assessment completed 
(n=12) 
Declined:  
Returned to work and unable to attend 
scheduled times (n=2) 
Not interested (n=3) 
Unable to make follow-up contact (n=1) 
6-month follow up (n=12) 
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Participant demographics and disease-related characteristics 
Baseline characteristics are represented in Table 2. All participants were female with a median 
age of 56 years (range 45-71). Mean BMI was 33.78 kg/m2; three (25%) were overweight (25-
29.9kg/m2), five were obesity class I (30-34.9kg/m2), two were obesity class II (35-39.9kg/m2), 
and two were obesity class III (≥40 kg/m2). Eight women had a history of breast cancer (67%), 
three colorectal cancer and one Non-Hodgkin’s lymphoma (NHL). Participants were on average 
31 months (range: 11-71) post cancer diagnosis. All except the participant with NHL had 
undergone surgery for their cancer (11/12 [92%]), ten (83%) had received chemotherapy, eight 
(67%) radiotherapy, and six (50%) breast cancer survivors were currently taking endocrine 
therapies (i.e. tamoxifen, anastrozole, or exemestane). At baseline, ten of the participants had 
at least one comorbid condition, with nine (75%) having more than one comorbidity. The most 
prevalent comorbidities were hypertension/cardiovascular disease (50%) and musculoskeletal 
disease/osteoarthritis (50%). Seven (58%) women were married or in a defacto relationship. At 
the time of study entry, six (50%) were employed, three (25%) had retired, and three (25%) 
were unemployed or on extended sick leave. 
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Table 2. Baseline demographic and disease related characteristics of participants (n = 12). 
 
Characteristic 
 
n 
 
% of participants 
Female  12 100 
Age 
    Median (SD) 56 (9.06)  
    Range 45-71  
Body Mass Index (kg/m2) 
    Overweight (25-30) 3 25 
    Obese (>30) 9 75 
Tumour Type   
    Breast 8 67 
    Colorectal 3 25 
    Lymphoma 1 8 
Time since diagnosis (months)  
    Mean (SD) 31(17.71)  
    Range 11 - 71  
Treatment 
    Surgery 11 92 
    Chemotherapy 10 83 
    Radiotherapy 8 67 
    Endocrine therapies 6 50 
    Trastuzumab 1 8 
Comorbidities* 
   No comorbidities 2 17 
   Diabetes 2 17 
   Hypertension/Cardiovascular   
disease 
6 50 
   Musculoskeletal/Osteoarthritis 6 50 
   Osteoporosis/ Osteopaenia 3 25 
   Anxiety/ Depression 1 8 
   Respiratory disease/Asthma 1 8 
Employment Status 
    Employed (Full-Time; Part-Time; Casual) 6 50 
    Unemployed/ extended sick  leave 3 25 
    Retired 3 25 
Marital Status 
    Married/De facto 7 58 
    Separated/Divorced 2 17 
    Single 3 25 
*9 participants had ≥1 comorbidity 
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Primary Outcome 
Attendance  
Attendance at the weight management clinic was 97% with only one participant not attending 
the 6 month visit due to employment responsibilities. During the 6 month program, there were 
no participant withdrawals. Of the expected 52 supervised exercise sessions per participant, 
71% were attended. The major reasons for non-attendance were staffing issues (AEP/Dietitian 
not available) (36%), patient-related health issues (23%) and employment-related issues or 
returning to work mid-intervention (24%). One participant returned to full time work, and 
another increased her work days at the 3-month time point. One participant had breast 
reconstruction surgery at 4 months. In total, 81% of dietary sessions were attended, with the 
primary reasons for non-attendance the same as above (50%, 13%, and 31% respectively). One 
participant did not attend any dietary sessions due to family obligations. 
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Table 3. Participant attendance at each component of the 6-month weight management program.  
 
Weight management sessions and 
maximum no. of sessions possible 
No. of sessions 
attended 
Mean (SD) 
Attendance 
% 
Reasons for non-attendance (%) 
Clinic Assessment and Behavioural 
Counselling 
 (n=3  visits/participant) 
3 (0.3) 97 Employment related (3) 
Supervised Exercise Sessions  
(n=52 sessions/participant) 
37 (7.4)  71 Health professional unavailable (36) 
Employment related (24) 
Patient related health issues  (23) 
Holiday (9) 
Family related issues (5) 
No Show (2) 
Logistic reasons (1) 
Dietary Sessions 
 (n=12 sessions/ participant) 
10 (3.1)  81 Health professional unavailable (50) 
Employment related (31) 
Patient related health issues (13) 
Holiday (6) 
Abbreviations: 
SD, standard deviation 
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Secondary Outcomes 
Body Composition  
At completion of the 6-month intervention, the mean weight loss was 4.9kg (range 0.1kg to -
19.6kg) and 5% of initial body weight (BW). One participant (WM011) did not attend any 
dietary sessions and was the only participant to gain weight. Participant WM012, who reduced 
her BW by 19.6kg (pre-intervention 122.8kg; post intervention 103.2kg), also reduced her 
fasting glucose by 8.7mmol/L (17.2mmol/L to 8.5mmol/L). Overall, at three months, there was 
no mean change in fat mass (FM) or fat free mass (FFM) percentage on bioelectrical impedance 
measurement, but at 6 months there was a 3% reduction in FM and a 2% increase in FFM.  
 
Overall, participants reduced their waist circumference (WC) by 3.8cm (range -13.2cm to 
+4.8cm). Two participants (17%) had increased WC measurements; one had commenced 
steroid treatment for polymyalgia rheumatica and one had abdominal bloating secondary to a 
bowel parasite. Despite reductions in WC, 11 (92%) participants still had measurements ≥88cm. 
Overall reductions were observed at 3 and 6 months for arm circumference (-1.5cm; range -
5.8cm to +0.6cm), calf circumference (-1.1cm; range -2.8cm to 0cm), triceps skinfold (-5.3mm; 
range -10.0mm to 0.6mm), and subscapularis skinfold (-5.3mm; range -19.8mm to +1.8mm). 
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Figure 2. Body weight, waist circumference, fat mass and fat 
free mass group mean changes from baseline to post-
intervention (6-months) 
Waist circumference
(cm)
Body Weight (kg)
Fat Free Mass (%)
Fat Mass (%)
60.00
65.00
70.00
75.00
80.00
85.00
90.00
95.00
100.00
105.00
110.00
115.00
120.00
125.00
0 3 6
B
o
yd
 w
ei
gh
t 
(k
g)
 
Time (months) 
Figure 3. Body weight change from baseline to post-
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post-intervention (6-months) 
WM001
WM002
WM003
WM004
WM005
WM006
WM007
WM008
WM009
WM010
WM011
WM012
21 
 
 
 
30.00
35.00
40.00
45.00
50.00
55.00
0 3 6
Fa
t 
M
as
s 
(%
) 
Time (months) 
Figure 6. Percentage fat mass change from baseline to post-
intervention (6-months) 
WM001
WM002
WM003
WM004
WM005
WM006
WM007
WM008
WM009
WM010
WM011
WM012
22 
 
Table 4. Body composition measures and change from baseline to post-intervention (6-months) (n=12) 
 
Measurement Baseline 
Mean (SD) 
Range 
3 months 
Mean (SD) 
Range 
6 months 
Mean (SD) 
Range 
Mean change from baseline  
To post-intervention  
Mean (95% CI) % 
Weight (kg) 88.4 (15.29) 
65.6 – 122.8 
85.2 (10.91) 
65.9 – 104.1 
84.0 (11.79) 
64.8 – 103.2 
-4.9 (-9.03, -0.79) -5 
Fat Mass (%) 43.7 (5.47) 
33.0 – 50.0 
43.6 (4.16)* 
34.0 – 49.0 
41.6 (5.15)** 
33.0 – 47.0 
-1.2 (-2.33, -0.12) -3 
Fat Free Mass (%) 56.3 (5.51) 
49.8 – 67.3 
56.4 (4.16)* 
50.6 – 66.5 
58.4 (5.15)** 
53.4 – 66.9 
1.2 (+0.12, 2.33) +2 
Waist Circumference 
(cm) 
105.4 (13.61) 
86.8 – 131.6 
102.2 (11.06) 
87.7 – 119.0 
100.5 (12.83) 
79.0 – 120.2 
-3.8 (-7.0, -0.6) -4 
Arm Circumference 
(cm) 
35.3 (4.12) 
29.4 – 42.0 
34.8 (3.04) 
30.0 – 39.3 
33.9 (3.23)*** 
29.3 – 38.5 
-1.5 (-2.8, -0.3) -4*** 
Calf Circumference 
(cm) 
40.4 (2.69) 
37.5 – 46.8 
39.6 (1.81) 
37.3 – 43.0 
39.3 (2.11)*** 
37.0 – 44.0 
-1.1 (-1.7, -0.5) -3*** 
Triceps Skinfold (mm) 31.8 (4.12) 
24.8 – 38.8 
27.3 (4.23) 
18.4 – 32.0 
26.4 (4.74)*** 
19.7 – 33.8 
-5.3 (-7.4, -3.1) -17*** 
Subscapularis skinfold 
(mm) 
34.0 (8.15) 
21.6 – 49.2 
31.6 (7.69) 
21.8 – 44.8 
29.2 (6.97)*** 
18.8 – 40.3 
-5.3 (-9.1, -1.5) -15*** 
Abbreviations: SD, standard deviation; CI, confidence interval 
*n = 10 (equipment failure) 
**n =9 (equipment failure) 
*** 11 available subjects 
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Physical Activity Levels  
Patients self-reported markedly higher rates of physical activity than was detected on the 
accelerometers. At baseline, participants (n= 10) reported doing 79 minutes of moderate and 
20 minutes of vigorous activity per day; with 80% self-reporting meeting the HEPA category of 
achieving greater than the recommended guidelines.  At 6 months, participants reported 108 
minutes of moderate and 22 minutes of vigorous activity per day, with 58% (n=7) categorised 
into HEPA.  At both time points, no participant was categorised as sedentary or inactive.  
Ten participants wore the accelerometer and 7 participants had a minimum of 4 valid days of 
data at both time points. Accelerometers recorded a mean of 32 minutes of moderate and 1 
minute of vigorous activity per day at baseline. At six months, participants had reduced their 
moderate activity by 7 minutes per day with no change seen in vigorous activity. Reasons for 
missing accelerometer data include technological issues, lack of sufficient available devices and 
one participant was in rehabilitation post-surgery. 
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Figure 7. Participant self reported physical activity on the IPAQ versus 
accelerometer measured physical activity at baseline and post-intervention (6-
months) 
Accelerometer moderate
activity
Accelerometer vigorous
Activity
IPAQ-SF moderate activity
IPAQ-SF vigorous activity
IPAQ-SF, International physiacl activity questionnaire short form. 
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Table 5. Participant self-report and objectively-measured physical activity levels from baseline to post-intervention (6-months) 
 
Measurement Baseline 
Mean  
n=10 
3 months 
Mean  
n=10 
6 months 
Mean  
n=12 
Mean change baseline to post-
intervention (95% CI)  
n=10 
IPAQ-SF 
Minutes of moderate 
activity per day (SD) 
79 (45.54) 74 (67.29) 108 (108.65) N/A 
Minutes of vigorous 
activity per day (SD) 
20 (21.38) 40 (73.41) 22 (43.90) N/A 
MET-min/week (SD)^ 6078 (2739.33) 5677 (5646.82) 5158 (4987.54) -963 (-5131.84, 3204.84) 
Activity Category 
Minimally Active n (%) 2 (20%) 6 (60%) 5 (42%)  
HEPA Active n (%) 8 (80%) 4 (40%) 7 (58%)  
Accelerometer (n=7) 
Minutes of light activity 
per day (SD) 
307 (50.80) N/A 351 (47.76) 45 (-10.36, 99.53) 
Minutes of moderate 
activity per day (SD) 
32 (11.00) N/A 25 (7.95) -7 (-17.32, 4.32) 
Minutes of vigorous 
activity per day (SD) 
1 (1.51) N/A 1 (1.98) 0.22 (-0.21,  0.66) 
Abbreviations: CI, confidence interval; SD, standard deviation; HEPA, health enhancing physical activity; IPAQ-SF, International Physical 
Activity Questionnaire- Short Form 
^ Includes minutes of walking per day 
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Nutritional Intake  
Based on the self- report 3-day food diaries participants reduced their daily total energy intake 
by 269 kilojoules (kJ) from baseline to 6 months. Daily macronutrient reductions were observed 
in protein (-2g), total fat (-10g) and carbohydrate (-1g) intakes. Additional macronutrients that 
contribute to changes in total daily energy intake (i.e. alcohol and dietary fibre) were measured 
but not recorded in this analysis. As depicted in figure 8, at baseline only 2 (17%) participants 
were meeting the daily fruit requirements, and none were meeting the intake of vegetables 
recommended by the Australian Guide to Healthy Eating. Following the program, four 
participants (33%) were meeting the daily recommended fruit intake, four (33%) the vegetable, 
and three (25%) participants both the fruit and vegetable guidelines.  
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Figure 8. Number of participants meeting dietary guidelines for 
daily fruit and vegetable intake at baseline and post-intervention  
2 or more serves fruit per
day
5 or more serves
vegetables per day
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Table 6. Participant self-reported daily nutritional intake at baseline and post-intervention (6-months) 
 
Measurement Baseline 
Mean (SD) 
n=11 
6 months 
Mean (SD) 
n=11 
Mean change baseline to post intervention (6 
months) (95% CI) 
n=11 
Total Energy 
Intake (kJ) 
6313 (1828.49) 6166 (1575.24) -269 (-2072.27, 1534.99) 
Protein (g) 84 (24.14) 82 (15.56) -2 (-25.76, 22.66) 
Total Fat (g) 59 (22.26) 49 (17.09) -10 (-29.37, 8.89) 
Carbohydrate (g) 159 (45.27) 160 (51.59) -1 (-44.03, 45.31) 
Abbreviations: 
SD, standard deviation; CI, confidence interval. 
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Exercise Testing 
There were nine participants who completed the treadmill submaximal test and maximal 
strength testing. Of these, only 8 completed the 6-month assessment. The reason for the 
missed assessment was due to a recent breast reconstruction. The remaining three participants 
completed the six-minute walk test and 30-second chair stand as an alternative due to 
contraindicated comorbidities (chronic pain, atrial fibrillation). As depicted in Table 7 
improvements were observed in aerobic fitness as measured by a submaximal treadmill test 
and/or six-minute walk test. Lower limb maximal strength assessed by a 1-repetition maximum 
test and functional assessment via a 30-second chair stand also improved from baseline to post-
intervention. Bilateral hand grip strength did not change over time. 
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Table 7. Participant self-report and objectively-measured physical activity levels from baseline to post-intervention (6-months) 
 
Measurement Baseline 
Mean (SD) 
 
3 months 
Mean (SD) 
 
6 months 
Mean (SD) 
 
Mean change from baseline 
to post-intervention (95% 
CI) 
Predicted V02max 
(ml/kg/min) 
n=8 
23.8 (7.13) 29.0 (7.58) 29.9 (5.63) 6.08 (1.34, 10.83) 
1-RM leg press (kg) 
n=9 
57.8 (13.28) 83.4 (24.43) 90.90 (29.04) 33.1 (-2.61, 14.61) 
Six minute walk test (m) 
n=3 
 506 (64.47) 556 (79.73) 562 (71.39) 56 (38.79, 73.21) 
30-second chair stand 
(repetitions) 
n=3 
10 (3.51) 15 (5.29) 16 (5.13) 6 (-2.61, 14.61) 
Hand grip strength-
dominant 
n=11 
24 (5.88) 26 (5.94) 25 (5.65) 0.2 (-2.12, 2.55) 
Hand grip strength – non 
dominant 
n=11 
24 (5.50) 25 (4.40) 25 (4.92) 0.5 (-1.77, 2.77) 
Abbreviations: 
 SD, standard deviation; CI, confidence interval; V02, maximal oxygen consumption; RM, repetition maximum. 
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Patient Reported Outcomes  
There were no changes in fatigue from baseline to post-intervention as reported by the FACIT 
fatigue 13-item subscale (Table 8). Similarly, there were no changes in global health or 
functional domains reported by the EORTC-QLQ C30.  No change in levels of distress on the 
Distress Thermometer was observed at 3 or 6 months. According to the DASS-21, there were no 
change in depression, anxiety or distress across all time points, with a high proportion of 
participant’s reporting moderate to extremely severe domain scores.  
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Table 8. Patient-reported outcome measures from baseline to post-intervention (6-months)  
 
Measurement Baseline (n=10) 
Mean (SD) 
Range 
3 months (n=10) 
Mean (SD) 
Range 
6 months (n=10) 
Mean (SD) 
Range 
Mean change from 0 to 
6 months (95% CI) 
Fatigue  
FACIT 13-item subscale (0-52) 
 
42 (6.17) 
34 – 49 
42 (8.68) 
27 – 52  
44 (5.76) 
24 - 50 
2 (-0.87, 5.27) 
Quality of Life (QOL) 
EORTC QLQ-C30 (0-100) 
Global Health QOL 
 
74 (14.93) 
50 - 100 
75 (18.43) 
42 - 100 
77 (17.03) 
42 – 100 
3 (-5.95, 10.95) 
Physical  functioning 
Range 
93 (5.84) 
87 - 100 
93 (8.58) 
80 - 100 
94 (9.14) 
60 - 100 
1 (-4.53, 7.20) 
Emotional functioning 
 
81 (21.71) 
42 - 100 
81 (21.53) 
42 - 100 
85 (17.03) 
33 - 100 
4 (-5.76, 13.54) 
Role functioning 
 
97 (10.54) 
67 - 100 
95 (11.25) 
67 - 100 
92 (21.15) 
33 - 100 
-5 (-20.95, 10.95) 
Social Functioning 
 
97 (10.54) 
67 - 100 
90 (16.10) 
67 - 100 
97 (10.54) 
33 - 100 
0 
Distress 
Distress Thermometer (0-10) 2 (2.07) 
0 - 6 
2 (2.47) 
0 - 7 
1 (1.10) 
0 - 6 
-1 (-1.78, 0.58) 
Number reporting ≥4  2 2 2 - 
Depression, Anxiety, Stress 
DASS-21 (n =9) (n=9)   
Stress score 21 (5.55) 
14 – 28 
22 (8.33) 
14 - 36 
18 (6.76) 
14 - 44 
-3 (-8.68, 2.18) 
Stress Severity Score –Moderate  
n (%) 
3 (25) 1 (8) 1 (8) - 
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Stress Severity Score –Severe  
n (%) 
2 (17) 3 (25) 0 (0) - 
Stress Severity Score –Extremely 
Severe  
n (%) 
0 (0) 1 (8) 3 (25) - 
Anxiety score 17 (4.37) 
14 - 28 
16 (3.97) 
14 - 26 
18 (7.80) 
14 - 40 
1 (-1.88 , 4.10) 
Anxiety Severity Score – moderate 
n (%) 
3 (25) 5 (42) 5 (42)  
Anxiety Severity Score – severe 
n (%) 
5 (42) 3 (25) 3 (25) - 
Anxiety Severity Score – extremely 
severe 
n (%) 
1 (8) 1 (8) 4 (33) - 
Depression score 19 (4.90) 
14 - 28 
19 (5.84) 
14 - 28 
17 (4.40) 
14 - 40 
-1 (-4.34, 1.84) 
Depression  Severity Score – 
moderate 
n (%) 
7 (58) 5 (42) 8 (67) - 
Depression  Severity Score – 
severe 
n (%) 
1 (8) 3 (25) 1 (8) - 
Depression Severity Score – 
extremely severe 
n (%) 
1 (8) 1 (8) 2 (17)  
Abbreviations: 
SD, standard deviation; CI, confidence interval; EORTC QLQ-C30, The European Organization for Research and Treatment of Cancer 30-item 
quality of life construct; DASS21, Depression, Anxiety and Stress Scale 21-item; FACIT-F, Functional Assessment of Chronic Illness- Fatigue Scale. 
FACIT-F Fatigue subscale: higher score indicate less fatigue; EORTC QLQ C30: higher score indicates higher response level. 
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Blood Results  
Fasting blood results are shown in detail in Table 9. There were minimal reductions in fasting 
glucose (-0.79mmol/L), total cholesterol (-0.26mmol/L) and triglycerides (-0.25mmol/L) from 
baseline to 6 months. With respect to fasting glucose, one participant decreased from 
17.2mmol/L to 8.5mmol/L and was directed by her endocrinologist to cease insulin medication. 
C-reactive protein (CRP) was stable in most participants over the 6 months but there was one 
outlier whose CRP increased over time (0 to 6 months). This was the participant who had a flare 
of her polymyalgia rheumatic. There were minimal changes from baseline to 6 months with 
insulin-like growth factor-1 (+0.38mmol/L) or haemoglobin levels (-0.73g/L). 
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Table 9. Participant blood results from baseline to post-intervention (6-months)  
 
Measurement Baseline 
Mean (SD) 
Range 
3 months 
Mean (SD) 
Range 
6 months 
Mean (SD) 
Range 
Mean change from 
baseline to post-
intervention 
 (95% CI) 
Fasting Glucose (mmol/L)  
n=11 
6.37 (3.63) 
4.3 - 17.20 
5.73 (1.46) 
4.70 - 10.00 
5.55 (1.02) 
4.40 - 8.50 
-0.79 (-2.57, 0.99) 
Total Cholesterol (mmol/L) 
n=11 
4.90 (0.87) 
3.80 – 6.40 
4.64 (0.93) 
3.50 – 6.10 
4.64 (0.82) 
3.60 – 5.90 
-0.26 (-0.87, 0.34) 
Triglycerides (mmol/L) 
n=11 
1.58 (0.70) 
0.70 – 2.60 
1.35 (0.63) 
0.90 – 2.90 
1.33 (0.59) 
0.80 – 2.40 
-0.25 (-0.52, 0.01) 
CRP (mg/L) 
n=8 
3.36 (2.90) 
0.80 – 9.00 
3.21 (2.19) 
0.60 – 6.90 
2.56 (1.46) 
1.00 – 19.40 
-0.80 (-2.61, 1.01) 
IGF-1 (mmol/L) 
n=9 
13.58 (3.22) 
7.10 – 19.60 
13.68 (2.85) 
9.20 – 19.20 
13.69 (4.43) 
8.10 – 22.00 
0.38 (-2.06, 2.82) 
Haemoglobin (g/L) 
n=11 
135.91 (7.78) 
126.00 – 149.00 
135.27 (7.99) 
123.00 – 146.00 
135.25 (7.36) 
123.00 – 144.00 
-0.73 (-4.22, 2.76) 
Abbreviations:  
SD, standard deviation; CI, confidence interval; CRP, C-Reactive Protein; IGF-1, Insulin-like Growth Factor-1. 
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Adverse Events 
One participant (#002) reported two adverse events during the program. Both events occurred 
a number of hours after a supervised exercise session. The first was paraesthesia requiring a 
hospital admission with a diagnosis of migraine. The second event was cardiac palpitations 
whilst at work. The participant works in a hospital emergency department and was treated at 
said place. No admission was required and participant was referred for a cardiology review with 
no positive diagnosis, and was given clearance to continue exercising. 
 
Program Satisfaction 
Seven participants (58%) completed the program satisfaction survey. All indicated that they felt 
the program was worth their time, had helped them to set and reach realistic goals, that the 
program leaders were well organised, and the Dietitian and AEP were knowledgeable and 
capable. All found the program enjoyable and intended to tell others about it. The most 
enjoyable aspects of the program were: interaction with and knowledge gained from the 
Dietitian and AEP (n=5), meeting and interacting with other study participants with similar 
experiences (n=4), and noticing improvements in fitness (n=2). Two participants identified the 
least enjoyable aspect of the program as having the blood tests, and getting up early in the 
winter months to attend sessions. 
 
Qualitative Analysis 
Ten participants (83%) were interviewed at the completion of the six month intervention. The 
topics of barriers and facilitators to the intervention were explored in telephone interviews 
with participants. Within each topic, a number of subthemes were identified. 
 
Facilitators to participation in the intervention 
The intervention staff members were identified as important facilitators, particularly through 
their support of participants and their professional expertise – contributing to participant 
adherence with the program.  Participants felt supported, heard, encouraged, and not judged. 
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“She knew what I could do, what I couldn’t do, and she was always very encouraging, 
very, and never judgmental or anything, she was very encouraging” – WM008. 
 
 Interactions between study participants were also valued. Participants reported not feeling 
pressure to perform and being able to share their feelings and experiences with other survivors 
more easily than with their personal friends or family.  
 
“We’re all cancer survivors in a little group and it made me more, well I have never been 
to a gym before, and it made me feel more comfortable because I was with like-minded people 
and you know, my level of fitness wasn’t very good so I didn’t feel any pressure. Just the 
overriding support were getting from the group has been brilliant. Rather spoilt actually” – 
WM004. 
 
Some participants described gaining benefit from individually prescribed programs tailored to 
their needs and being empowered to take control of their health.  
 
“I think it is very individualised which is helpful. Like you know, you have sessions with 
[AEP] and she just talks to you about you know, with your particular lifestyle what works what 
doesn’t, what are some of the challenges, how you might manage challenges differently, rather 
than a one size fits all approach”. – WM010 
 
The personalised education and tools that were provided were described as enablers to 
behaviour change. 
 
“I’m very much aware now. I mean I’ve always been a bit aware, a little bit. But I 
probably never had the opportunity to actually set the habits. I think it is the balance between 
food groups. Whereas before I may have been more inclined to think how many calories was 
that? She [dietitian] tried to get us away from that type of thing.” – WM001 
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Barriers to participation in the intervention 
The greatest challenge the participant’s identified was the limited availability of days and times 
sessions were held. The six participant’s working prior to and during the intervention suggested 
later or more frequent session times to allow greater flexibility. Another challenge was the time 
spent commuting to the study gym and other sessions. Not all participants lived within close 
proximity to the hospital; however this challenge was not a reason for their non-attendance. 
 
“I get public transport because I live far away, takes me one and a half hours to get there 
and takes me one and a half hours to come back.. now still dark and I work. Then just after you 
feel like oh its getting too dark and too cold to get up but I still put myself the alarm and there’s 
enough time to get up”. – WM003
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Discussion 
The evidence that obesity is a major risk factor for the development and recurrence of several 
types of cancer is now widely acknowledged by leading international cancer organisations2,11. In 
addition, the impact of being overweight or obese post cancer diagnosis results in poorer 
outcomes and higher risk of developing non-cancer related chronic health conditions including 
cardiovascular disease and Type II Diabetes. In this feasibility study, we implemented a 6-month 
(26-week), weight management program (WMP) using supervised exercise and in-person 
nutritional sessions, incorporating behavioural counselling methods at the Sydney Survivorship 
Centre, Concord Hospital. This study demonstrated the feasibility of implementing a weight 
management program in a hospital oncology outpatient setting.  We achieved a high 
attendance rate, and modest improvements in weight, body composition, fitness and 
nutritional intake.  
 
Getting participants to attend weight management programs is a primary factor impacting 
participant outcomes34,35. Of the eligible participants, this program was well received, with 60% 
(12 out of 20) approached enrolling into the study. During the intervention, attendance at all 
sessions was high with 97% at clinic consultations, 71% of supervised exercise sessions, and 
81% of dietary sessions. These attendance rates are inclusive of two participants who returned 
to work, another who had a breast reconstruction mid-intervention (months 3 to 4), and one 
participant who declined to attend any dietary sessions due to family commitments but who 
attended the exercise sessions. A Canadian phase II weight loss feasibility trial (n=14) run in an 
outpatient cancer centre setting, similar in design to our study required participants attend a 24 
week intervention, with two supervised exercise sessions per week and 16 dietary sessions over 
6-months36. This study reported that a mean of 67% of exercise and 67% of dietary sessions 
were attended, reflecting a slightly lower attendance rate than the current study results. 
However, we acknowledge the small sample size of our study.  
 
It was evident that return to work, which will be common in the survivorship setting, limited 
the ability of survivors to join the program or commit to the intervention, as there were limited 
38 
 
times offered due to staffing availability. Only early morning exercise sessions (7.00 – 10.00 
A.M) were available but offering further sessions after general work hours would be worth 
considering in an attempt to improve the attendance rates further. 
 
Overall, the participants had reductions in mean body weight, body fat percentage, and waist 
circumference, with a modest increase in fat free mass percentage. Overall the group achieved 
the desired 5% (4.9kg) reduction in body weight over six months, with decreased body fat of 3% 
and waist circumference of 3.8cm, as well as increasing their fat free mass by 2%. A 5% 
decrease in body weight has been shown to be of clinical significance, with improvement in  
health outcomes in non-cancer overweight/obese populations17 . However,  leading obesity and 
cardiovascular disease researchers have reported that body weight is a poor  indicator for 
changes in other body composition outcomes, including waist circumference, body fat, and lean 
body mass37. 
 
A number of randomised controlled trials in breast cancer survivors have demonstrated similar 
outcomes following 6-month WMP interventions. One intervention, facilitated by an exercise 
physiologist and dietitian trained in behavioural modification reported a 6.4% reduction in body 
weight35,38. Another trial, facilitated by a commercial-gym trainer, reported only a 3.3% 
reduction with low attendance at sessions (mean 1.1 of 3 sessions per week)38. Combined, 
these results point to the importance of context and professional skills of staff delivering 
interventions for successful behaviour change. 
 
Participant’s self-reported high levels of daily physical activity with all participants categorised 
as meeting PA guidelines. What is particularly evident is the discrepancy between the self-
reported levels of PA and those seen in the objectively measured accelerometer data.  This 
apparent discrepancy has been reported in a number of other studies. Prince et al 
systematically reviewed comparisons of direct versus self-report measures of PA in adults, 
finding no clear answer as to whether objectively or self-report measures of PA were more 
accurate39. We are uncertain why the amount of physical activity measured by accelerometers 
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decreased over time in our study.   A minimum of four days of valid data were required, so it is 
possible that for some participants the days captured did not include supervised exercise 
sessions for that week. Further, accelerometers in not particularly effective at detecting cycling, 
yoga, or resistance training, and cannot be used for any water-based activities such as 
swimming, so a number of these activities are likely under-reported in this study.  
 
Another possible explanation for the high level of baseline PA is our participants had already 
attended the Survivorship Clinic and completed all six sessions of the ENRICH program. The 
rationale for these inclusion criteria was to ensure commitment from the participants and to 
reduce the number of withdrawals or dropouts, as well as ensuring a standardised baseline of 
knowledge amongst participants in the WMP. This meant that prior to study entry, all 
participants had already had an individual consultation with the AEP and dietitian, as well as 
having been provided materials and group sessions on physical activity, exercise and healthy 
eating for cancer survivors.  It is likely therefore, that they had instituted improvements to their 
PA and diet prior to the baseline assessments, particularly as their self-reported PA levels were 
higher than that of the general cancer survivor population.  
 
In our study, minimal changes from baseline to post-intervention were apparent in fatigue, 
quality of life, distress, depression, anxiety or depression. Marked changes were apparent in 
some individuals, but due to the small sample size it is not possible to draw conclusions about 
the sample overall. Although participants reported a high level of affective symptoms with 
minimal change over time, this was not given as a reason for non-attendance or seen as a 
barrier to participation. Furthermore, a clinical psychologist had reviewed each patient during 
their survivorship clinic visit, and recommendations and referrals made for further review when 
it was believed appropriate. 
 
Our study participants reported many benefits and positives during the participant program 
evaluation and qualitative interviews. A similar study in overweight and obese breast cancer 
survivors included qualitative interviews post intervention36,40. Participants described an 
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important facilitator to attending the program, as the presence of other cancer survivors, 
providing a feeling of normality. While they still faced barriers including logistical issues (work, 
family) and ongoing symptoms (fatigue) they attended the sessions with determination to 
improve their health40. The pattern of responses across these two studies suggests the 
programs are motivating for participants to engage with and help with adherence to lifestyle 
changes in the longer term. 
 
Limitations 
Limitations of this feasibility study are the small sample size and absence of a control group. 
However, larger RCTs have consistently shown that overweight patients randomised to control 
groups without an intervention are generally not able to lose weight or sustain weight loss.  
 
Our population was a heterogeneous sample as it included the solid tumour types seen in the 
Sydney Survivorship Clinic (breast, colorectal, lymphoma, upper gastrointestinal). Observational 
data identifies obesity as a risk factor for a number of cancers including colorectal and breast 
cancer. To date, RCTs using exercise and nutrition for the purpose of weight loss have primarily 
concentrated on breast cancer populations21.  There has been only one diet and exercise 
intervention for overweight/obese cancer survivors that has included breast, colorectal and 
prostate cancer survivors. The primary outcome of this study was physical function, while 
weight loss, PA levels and quality of the diet were secondary outcomes41. Results indicated 
improvements in weekly PA and diet quality after the 12-month intervention, which stabilised 
with no further significant improvement at 24 months. Significant reductions in weight were 
seen from baseline to 24 months (p<0.05). 
 
As previously mentioned, we did not control in detail the diet and exercise regimes of the 
participants. This intervention was designed to allow flexibility and for the participant to make 
informed decisions as to how best to modify their lifestyle. In a clinical setting, this may allow 
patients to better adapt to their real life scenarios e.g. return to work. Although we collected 
food diaries, we did not collect physical activity diaries. As noted in the study by James EL, et al 
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(2015), the pre-post PA change was only significant when ‘additional activities’ not captured by 
pedometry were added to the raw pedometer counts25. This may explain why there was 
minimal change in pre-post accelerometry-measured, activity levels, as activities such as 
swimming, yoga and resistance training were not captured. 
 
Strengths 
A main strength of this study was the combination of exercise, nutrition and behavioural 
counselling as the foundations for the program. In non-cancer populations, the three 
components together have been shown to produce the best outcomes for addressing weight 
loss and body composition changes19. Another strength was the professional and experienced 
facilitators used to deliver the intervention. Oncology AEP and Dietitian’s are trained in 
modifying interventions for cancer survivors who may be at a higher risk of adverse events as a 
result of different cancer treatments42,43. Both the AEP and dietitian in our study were 
experienced in treating oncology populations and trained in behavioural change counselling.  
Participants highlighted the staff’s knowledge and encouragement as key facilitators to 
continued attendance in the program. Of the current weight loss trials published, only the 
ENERGY and LEAN trials have described the use of both an AEP and dietitian in delivering the 
intervention22,35.  
 
Future Directions 
Recruitment to the study is ongoing with a planned sample size of 20 patients and longer follow 
up of 12 and 24 months post baseline.  This will determine whether any of the benefits seen at 
six months are sustained.   If the WMP continues to prove feasible we plan to incorporate this 
as routine practice, offering it to all overweight/obese patients attending the Survivorship Clinic 
who have completed the preparatory ENRICH program. Consideration of feasibility of providing 
the program also needs to be considered from a staff and resource perspective.   
 
Conclusion 
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Our aim was to evaluate the feasibility of translating current knowledge of multi-disciplinary 
weight management programs for cancer survivors into a hospital outpatient setting.    
 
Our results confirm that overweight and obese cancer survivors are willing to make the 
commitment and attend an intensive exercise and nutrition weight management program. The 
intervention enabled participants to make positive changes to their weight, body composition 
and nutritional intake. Despite ongoing impacts of stress, anxiety, depression and distress, 
participants were able to overcome these psychological issues to attend sessions in an 
environment that was encouraging, supportive and individualised. Longitudinal data are now 
required to determine if weight loss is sustained long term.  
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TREND Statement checklist 
Paper Section/ 
Topic 
Item 
No. 
Descriptor Reported 
Y Page 
No. 
Title and Abstract 
Title and 
abstract 
1 Structured abstract recommended Y Iv 
Information on target population or study sample Y Iv 
Introduction 
Background 2 Theories used in designing behavioral interventions Y 3 
Methods 
Participants 3 Eligibility criteria for participants, including criteria at 
different levels in recruitment (e.g., cities, clinics, subjects) 
Y 4 
 
Method of recruitment (e.g., referral, self-selection) Y 4 
Recruitment setting  Y 4 
Interventions 4 Details of the interventions intended for each study 
condition and how and when they were actually 
administered, specifically including: 
  
Content: what was given? Y 5 
Delivery method: how was the content given? Y 5 
Unit of delivery: how were the subjects grouped during 
delivery? 
Y 5 
Deliverer: who delivered the intervention? Y 5 
Setting: where was the intervention delivered? Y 5 
Exposure quantity and duration: how many sessions or 
episodes or events were intended to be delivered? How 
long were they 
intended to last? 
Y 5 
Time span: how long was it intended to take to deliver 
the intervention to each unit? 
Y 5 
Activities to increase compliance or adherence N/A  
Objectives 5 Specific objectives and hypotheses Y 4 
Outcomes 6 Clearly defined primary and secondary outcome 
measures 
Y 8 
Methods used to collect data and any methods used to 
enhance the quality of measurements 
Y 8 
Sample Size 7 How sample size was determined Y 12 
Unit of Analysis 8 Description of the smallest unit that is being analyzed to 
assess intervention effects (e.g., individual, group, or 
community) 
Y 11 
Statistical 
Methods 
9 Statistical methods used to compare study groups for 
primary methods outcome(s) 
Y 11 
Statistical software or programs used Y 11 
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Results 
Participant 
flow 
10 Flow of participants through each stage of the study: 
enrollment, assignment, allocation, and intervention 
exposure, follow-up, analysis (a diagram is strongly 
recommended) 
Y 13 
Enrollment: the numbers of participants screened for 
eligibility, found to be eligible or not eligible, declined 
to be enrolled, and 
enrolled in the study 
Y 13 
Assignment: the numbers of participants assigned to a 
study condition 
Y 13 
Allocation and intervention exposure: the number of 
participants assigned to each study condition and the 
number of participants who received each intervention 
Y 13 
Follow-up: the number of participants who completed 
the follow- up or did not complete the follow-up (i.e., 
lost to follow-up), by study condition 
Y 13 
Description of protocol deviations from study as 
planned, along with reasons 
Y 16 
Recruitment 11 Dates defining the periods of recruitment and follow-up Y 13 
Baseline Data 12 Baseline demographic and clinical characteristics of 
participants in each study condition 
Y 14 
Numbers 
analysed 
13 Number of participants (denominator) included in each 
analysis for each study condition, particularly when the 
denominators change for 
Y 17, 22, 
24, 26, 
28, 30, 
33 
Outcomes 
and 
estimation 
14 For each primary and secondary outcome, a summary 
of results for each estimation study condition. 
Y 13 
Adverse 
events 
15 Summary of all important adverse events or unintended 
effects in each study condition (including summary 
measures, effect size estimates, and confidence 
intervals) 
Y 34 
Discussion 
Interpretation 16 Interpretation of the results, taking into account study 
hypotheses, sources of potential bias, imprecision of 
measures, multiplicative analyses, and other limitations 
or weaknesses of the study 
Y 37 
Discussion of the success of and barriers to 
implementing the intervention, fidelity of 
implementation 
Y 40 
Discussion of research, programmatic, or policy 
implications 
Y 37 
Generalizability 17 Generalizability (external validity) of the trial findings, Y 37 
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taking into account the study population, the 
characteristics of the intervention, length of follow-up, 
incentives, compliance rates, specific sites/settings 
involved in the study, and other contextual issues 
Overall 
evidence 
18 General interpretation of the results in the context of 
current evidence and current theory 
Y 37-42 
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reporting quality of nonrandomized evaluations of behavioral and public health 
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Evaluation of Weight Management Program in Cancer Survivors 
 
Information for Participants 
 
You are invited to participate in a service evaluation process of the Weight Management 
Program at the Sydney Survivorship Centre. The results of this study will help the survivorship 
care team understand how to improve the service to make it better for the future. This 
Information Sheet will tell you about what is involved in this project and help you decide 
whether or not you wish to take part.  Please read this information carefully.  If there is anything 
you do not understand or if you feel you need more information about anything, please ask.  
Before you make a decision, please feel free to talk things over with a relative, a friend or your 
own doctor. 
  
Why have I been asked to take part? 
You have been invited to take part in this project because you have decided to participate in the 
Weight Management Program at the Sydney Survivorship Centre. We would like to know if 
people are able to stick to a 12-month program. 
  
Studies have shown that weight gain whilst receiving treatment for cancer is common. Other 
studies have shown that regular physical activity and healthy eating help to decrease body weight 
after finishing these treatments.  Being above a healthy weight range and not being very 
physically active are risk factors for certain types of cancer and increase the risk of some cancers 
coming back. We are interested in determining if our program is effective in helping people lose 
weight and keep it off over a long period of time through a change in lifestyle. 
 
Who is conducting this work? 
This evaluation is being carried out in the Sydney Survivorship Centre at Concord Repatriation 
General Hospital. The people responsible for the study are:  
 
 Ms Jane Turner, Exercise Physiologist and Research Officer Sydney Survivorship Centre, 
Concord Repatriation General Hospital and Centre for Medical Psychology & Evidence-
based Decision-making, University of Sydney 
 Dr Cindy Tan, Dietician and Research Fellow Sydney Survivorship Clinic, Concord 
Repatriation General Hospital 
 A/Prof. Janette Vardy, Medical Oncologist, Sydney Survivorship Centre and University of 
Sydney; 
 Dr Haryana Dhillon, Centre for Medical Psychology & Evidence-based Decision-making, 
University of Sydney 
 
How many people will take part? 
Up to 50 people who have decided to participate in the weight management program will take 
part in this project. 
 
What is involved?  
The Weight Management Clinic is a new program established through the Sydney Survivorship 
Centre, Concord Cancer Centre. If you are interested in taking part in this study, the majority of 
the intervention and assessments will be standard practice for this program.  This means that 
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youwill be completing all components of the program whether you decide to participate in this 
study or not. You may be asked for additional information as listed below if you agree to 
participate in this study .  
 
Additional items for assessment for this evaluation include: 
 Completion of a hunger questionnaire 
 Wearing of an accelerometer for a 7-day period. This is a small, light device that you 
wear around your hips (like a belt). The accelerometer records your level of activity over 
a period of time. 
 Additional blood collection to see if certain hormones affect appetite. 
 Additional blood collection for future research 
We will ask you to complete these measures at the beginning of the program, then 3, 6 and 12 
months later.  
 
We will also ask you to take part in an interview at 6 months into the program with the study 
coordinator or one of the principal investigators. The interview will be recorded on a small 
handheld recorder, and then written out. The purpose of the interview is to give you an 
opportunity to share with us your experience and views about exercise, nutrition, and the impact 
this this has on your general wellbeing.  
 
The main components of the weight management program that require your involvement are 
attendance at clinics, exercise sessions in the Survivorship Gym and Dietary sessions. As a part 
of this evaluation, we will be recording how many sessions of each component you attend over 
the course of a 12 month period.  
 
Blood Samples 
We would like to collect some extra blood samples from everyone participating in this 
evaluation; these blood samples are in addition to those necessary for the usual follow-up. We 
will be collecting approximately 13mL of extra blood for the study. These blood samples would 
be collected on 3 occasions: now and in 6 and 12 months time. They will be used to measure 
hormones that affect appetite. These will help us to understand more about hunger and the body. 
We would also like to collect blood to store for future research projects. Please note that any 
future research using these blood samples will be reviewed by an appropriate Ethics Committee. 
 
Taking part in the blood banking part of this study is voluntary. You may choose not to take part, 
or may at any time withdraw your consent for this portion of the study and ask that the collected 
blood samples not be used.  
 
Deciding not to take part, or deciding to withdraw your consent for this portion of the study later, 
will not result in any penalty or loss of benefits to which you are entitled. If you decide to stop 
participating, and no longer want your blood samples to be used in this research, you should tell 
your doctor. Your doctor will notify the researchers responsible for the tissue bank, who will 
ensure the samples are destroyed.  
If tests have already been done on your sample and included in an analysis or publication, it will 
not be possible to withdraw these. 
 
The identification that will be on your blood samples kept in the bank may include your patient 
identification number, study code, and initials.  
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Samples will only be given to researchers whose proposals have been approved and who are 
bound by a confidentiality agreement. Any research done on your blood will have been approved 
by a research ethics board. A research ethics board oversees the ethical conduct of a study, 
including protection of patient rights, confidentiality and safety.  
 
Reports about any research done with your samples will not be given to you or your doctor. 
These reports will not be put in your medical records. The research using your samples will not 
affect your care. 
 
In the future, people who do research with your sample may need to know more about your 
health. While the researchers coordinating this study may give them reports about your health, 
they will not give them your name, address, phone number or any other information that will let 
them know who you are. 
 
As part of future studies, researchers may want to do genetic testing on your blood to see 
whether your cancer may be hereditary (run in your family). If genetic testing is done, reports 
about the results will not be put into your medical records. Your results will not be given to 
people who are not involved in the research (for example, your employer, insurance company). 
Every effort will be made to protect your privacy and the confidentiality of your results. Please 
indicate if we can use your samples for genetic testing at the end of this consent form. 
 
How long will I be in the study? 
You would be in the study for 12 months. 
 
The baseline assessment will take 120 minutes and you will be seen by a dietitian and an 
exercise physiologist.  Follow up clinic visits will take 1 hour. The questionnaires will take 
around 30 minutes to complete, excluding the 7-day exercise and food diary. The supervised 
exercise sessions will be for an hour twice per week for 6 months. There will be a total of 12 
nutrition sessions lasting 30 minutes each time for the same 6 month period.  
 
Study Information 
All of the information collected as part of the study will remain at Concord Repatriation General 
Hospital where it will be included in the electronic study database and where the statistical 
analysis of the study results will be done.  While you are participating in the study we will keep 
your name and contact details; keeping these details will allow us to contact you for follow-up 
visits and questionnaires. No one looking at the information stored in the study questionnaires 
and database will be able to tell who you are. The information collected will be kept for at least 
five years. When the information is destroyed this will be done using secure destruction 
methods. 
 
What are the possible risks of taking part? 
From a cancer point of view there are no known risks; the only risks are associated with the 
physical activity in people with a serious cardiac condition or respiratory disease. It will not 
change your treatment or follow-up with your treating doctor in any way.  
 
Blood samples will be taken by experienced staff by inserting a small needle into an arm vein. 
Trained staff at the hospital will be involved in this study. Collection of blood may involve some 
minor discomfort, bruising and on rare occasions local infection. 
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What are the possible benefits of taking part? 
The aim of this evaluation is to determine how many clinics, exercise sessions and dietary 
sessions people are able to attend over 12 months. 
 
Regular contact with the Exercise Physiologist and Dietitian over the next 12 months may help 
you to initiate and maintain any lifestyle changes that you have been thinking about since your 
diagnosis. 
 
How will information about me be kept private? 
If you participate, you will be given a code number so your name does not appear on any 
transcripts, records or questionnaires. The audio recordings and transcripts will be kept in a 
locked filing cabinet that only the research team will be able to access. The records will be 
destroyed 7 years after the study is completed via a secure method following hospital and 
university research requirements. Anything you say will be held in strict confidence and will not 
be disclosed to the medical staff, except as required by law. A report of the study will be 
submitted for publication, but you will not be identifiable in such a report. 
 
Compensation  
In no way does signing the Participant Consent Form waive your legal rights nor does it relieve 
the investigators or Concord Repatriation General Hospital from their legal and professional 
responsibilities. If you become ill or physically injured, please let your doctor know. 
Whom can I call if I have questions or problems? 
If you would like to know more at any stage, please feel free to contact Jane Turner, the 
researcher running this study on (02) 9767 6836 or jane.turner@sydney.edu.au. This information 
sheet is for you to keep. If you agree to participate in the study, please sign the accompanying 
consent form. Thank you for considering this invitation. 
 
Ethics Approval: 
This evaluation has been approved by the Human Research Ethics Committee – Concord Zone 
of the Sydney Local Health District. Any person with concerns or complaints about the conduct 
of this project should contact the Executive Officer on 02 9767 5622 and quote protocol number 
CH62/6/2014-121-J Turner. 
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Weight Management Program for Cancer Survivors 
 
PARTICIPANT CONSENT FORM 
 
I, ……………………………………………………………………………. [name] of 
 
……………………………………………...………………....... [address] have read 
 
and understood the Information for Participants on the above named research study and have 
discussed the study with 
 ……………………………………………………………………………………… 
 
I have been made aware of the procedures involved in the study, including any known or 
expected inconvenience, risk, discomfort or potential side effect and of their implications as far 
as they are currently known by the researchers. 
 
I hereby give permission for the medical practitioners, other health professionals, hospitals or 
laboratories outside this hospital, to release information concerning my disease and treatment 
which is needed for this trial and understand that such information will remain confidential. 
 
I freely choose to participate in this study and understand that I can withdraw at any time. 
 
I also understand that the research study is strictly confidential. 
 
I hereby agree to participate in this research study. 
 I agree to allow my blood samples to be collected for the purposes described here. 
 
 
 I agree to allow my blood samples to be used for future research 
 I agree to allow my blood samples to be used for genetic testing to see if my cancer may be 
hereditary. 
 
 I do not agree to allow my samples to be used for genetic testing to see if my cancer may be 
hereditary. 
 
 
 
Name: .......................................................................................................  
 
Signature:  ........................................................................................................ 
 
Date:  ........................................................................................................  
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WeMICS_Schedule of study investigations 
Weight management program timing of outcome assessment 
 
Outcome 
Measures 
Procedures Baseline 3 Month 6 Month 12 Month 
Demographics Gender, age, 
education, 
employment status, 
cancer diagnosis and 
treatment, weight 
history 
X    
Body Composition  Bioimpedance 
analysis, Skinfold 
measures, girth 
measures, BMI 
X X X X 
Physical Function Graded submaximal 
exercise test, 6MWT, 
hand grip 
dynamometry, 
maximal leg strength 
X X X X 
Nutritional Status 3-day weighed food 
diary 
X X X X 
Fasting Blood Test Full blood count, EUC, 
LFT, glucose, lipids, 
iron studies, sex 
hormones, vitamin D, 
vitamin B12, TSH, IGF-
1, CRP, Albumin,  
X X X X 
Blood Collection -
Other 
Investigations 
Ghrelin, peptide YY, 
DNA (baseline only), 
future research 
(baseline only) 
X X X X 
Patient Reported 
Outcomes 
DASS 
FACIT-F fatigue 13 
item subscale 
Distress 
Thermometer 
EORTC QLQ-C30 
IPAQ-SF 
Hunger Scale 
X X X X 
Physical Activity 
Behaviour 
Actigraph X  X X 
Qualitative Semi-structured 
Interviews 
  X  
Program 
Evaluation 
   X  
Adverse Events  X X X X 
Abbreviations: BMI, body mass index; 6MWT, six-minute walk test; DASS, Distress, Anxiety and Depression Scale; FACIT-F, 
functional assessment of chronic illness therapy – fatigue; EORTC-QLQC30, The European Organisation for Research and 
Treatment of Cancer Quality of Life Questionnaire; IPAQ-SF, International physical activity questionnaire short form. 
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            Patient Initials:                       Date of birth:                                                Hospital ID: 
           - -                                        .   .                                    
                (First- Middle-Last)                 ((dd/mm/yyyy)                                                                        (Postcode) 
PATIENT REGISTRATION 
 
 
 
 
    Patients must meet ALL of the following criteria to be eligible for the study.   
    Indicate √ = Yes;  X = No;  or NA = Not Applicable. 
 
1. 
  
Diagnosis of solid tumour 
 
Type: ______________________                                          Stage: ________                                      
            (Breast/Colorectal/Other: Please Specify)                                                   (I / II / IIIA / IIIB / IV)                                                     
 
 
2. 
  
Completion of Surgery 
Date of completion:  ____ ____ / ____ ____ /____ ____   (dd/mm/yy)    or    N/A   
3. 
  
Completion of Chemotherapy 
Date of completion:  ____ ____ / ____ ____ /____ ____   (dd/mm/yy)    or    N/A   
4. 
  
Completion of Radiotherapy 
Date of completion:  ____ ____ / ____ ____ /____ ____   (dd/mm/yy)    or    N/A   
5.      
  
Body Mass Index (BMI) >=25kg/m
2 
6. 
  
Has attended the Sydney Survivorship Clinic and been reviewed by Medical Oncologist, Nurse Specialist, Psychologist, 
Dietitian, and Exercise Physiologist  
Date attended:  ____ ____ / ____ ____ /____ ____   (dd/mm/yy)     
 
7. 
  
Completed ENRICH Program 
Date completed:  ____ ____ / ____ ____ /____ ____   (dd/mm/yy)     
8. 
  
 Ability and willingness to complete the patient-reported outcome questionnaires, physical activity questionnaires and logs 
in English. 
9. 
  
No pre-existing significant co-morbid conditions precluding participation in a physical activity programme, as determined 
by the investigator. 
10. 
  
 Medically fit to participate in a physical activity program, as determined by patient’s oncologist. 
11. 
  
Patient has given written informed consent. 
Date of consent:  ____ ____ / ____ ____ /____ ____    (dd/mm/yy)            Version of consent form signed: ___ 
12. 
  
Patient has consented to additional blood collection (Ghrelin, Peptide YY, DNA, Future Research) 
Date of consent:  ____ ____ / ____ ____ /____ ____    (dd/mm/yy)            Version of consent form signed: ___ 
 
   
   Investigator name:  ___________________________________     Signature: ___________________________________                   
            
   Date:  ____ ____ / ____ ____ /____ ____    (dd/mm/yy) 
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AEP NAME: AEP SIGNATURE: DATE: 
  
EXERCISE PHYSIOLOGY ASSESSMENT 
Cancer Type 
Treatment 
CTh                         Surgery  
RTh                         Hormonal/EndocrineTherapies 
Herceptin 
 
Identified Problems 
Fatigue                      
Neuropathy               
Lymphoedema          
 
Major Medical Conditions  
 
 
 
 
Medications 
 
 
 
 
Assessment 
Height Weight 
BMI  
 
RHR:                                       BP: 
 
Anthropometry 
Skinfold 
Site Test 1 Test 2  Test 3 Mean 
Triceps     
Subscapular     
Medial Calf     
 
Girths 
Site Test 1 Test 2  Test 3 Mean 
Waist     
ArmRelaxed     
Calf     
 
EP/ Client Discussion Outcomes 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Next Clinic Review 
 
 DIETITIAN NAME: DIETITIAN SIGNATURE: DATE: 
 
DIETITIAN ASSESSMENT 
Grip Strength Test 1  Test 2 Test 3 Average 
Right     
Left     
 
 
BIA 
Age Direct Z Ph R Xc 
BMI 
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 Participant completed questionnaires  
 
 
Please read the following information carefully before you begin the questionnaire.  
 
This questionnaire contains questions about how your treatment with chemotherapy 
has affected your life so far.  It involves five parts and will take approximately 15-20 
minutes to complete.  
 
Please try to answer the questions as accurately and honestly as possible. 
REMEMBER: Your responses are entirely confidential – no one involved in your 
treatment or ongoing care will have access to them. Only the researchers 
involved in the study will be able to view your responses and when they do they will 
only see your confidential participant number, not your name.  
 
Thank you for taking the time to complete the questionnaire.  
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DAS S 21 Name: Date: 
Please read each statement and circle a number 0, 1, 2 or 3 which indicates how much the statement applied to you 
over the past week.  There are no right or wrong answers.  Do not spend too much time on any statement. 
The rating scale is as follows: 
0  Did not apply to me at all 
1  Applied to me to some degree, or some of the time 
2  Applied to me to a considerable degree, or a good part of time 
3  Applied to me very much, or most of the time 
 
1 I found it hard to wind down 0      1      2      3 
2 I was aware of dryness of my mouth 0      1      2      3 
3 I couldn't seem to experience any positive feeling at all 0      1      2      3 
4 I experienced breathing difficulty (eg, excessively rapid breathing, 
breathlessness in the absence of physical exertion) 
0      1      2      3 
5 I found it difficult to work up the initiative to do things 0      1      2      3 
6 I tended to over-react to situations 0      1      2      3 
7 I experienced trembling (eg, in the hands) 0      1      2      3 
8 I felt that I was using a lot of nervous energy 0      1      2      3 
9 I was worried about situations in which I might panic and make 
a fool of myself 
0      1      2      3 
10 I felt that I had nothing to look forward to 0      1      2      3 
11 I found myself getting agitated 0      1      2      3 
12 I found it difficult to relax 0      1      2      3 
13 I felt down-hearted and blue 0      1      2      3 
14 I was intolerant of anything that kept me from getting on with 
what I was doing 
0      1      2      3 
15 I felt I was close to panic 0      1      2      3 
16 I was unable to become enthusiastic about anything 0      1      2      3 
17 I felt I wasn't worth much as a person 0      1      2      3 
18 I felt that I was rather touchy 0      1      2      3 
19 I was aware of the action of my heart in the absence of physical 
exertion (eg, sense of heart rate increase, heart missing a beat) 
0      1      2      3 
20 I felt scared without any good reason 0      1      2      3 
21 I felt that life was meaningless 0      1      2      3 
 
(Appendix 8) WeMICS: Weight Management in Cancer 
Survivors 
PID  - 
Date: -- 
 
Version 2, 10 September 2014         Page 3 of 20 
 
 
FACT-F 
 
By circling one (1) number per line, please indicate how true each statement has been for 
you during the past 7 days. 
 
 
 
 
ADDITIONAL CONCERNS 
 
Not 
at all 
A little 
bit 
Some-
what 
Quite 
 a bit 
Very 
much 
 
 
 
 
HI7 I feel fatigued .........................................................................0 
 
 1 2 3 4 
 
HI 
12 
I feel weak all over .................................................................0 
 
 1 2 3 4 
 
An1 I feel listless (“washed out”)  .................................................0 
 
 1 2 3 4 
 
An2 I feel tired ...............................................................................0 
 
 1 2 3 4 
 
An3 I have trouble starting things because I am tired ...................0 
 
 1 2 3 4 
 
An4 I have trouble finishing things because I am tired .................0 
 
 1 2 3 4 
 
An5 I have energy ..........................................................................0 
 
 1 2 3 4 
 
An7 I am able to do my usual activities.........................................0 
 
 1 2 3 4 
 
An8 I need to sleep during the day ................................................0 
 
 1 2 3 4 
 
An 
12 
I am too tired to eat ................................................................0 
 
 1 2 3 4 
 
An 
14 
I need help doing my usual activities .....................................0 
 
 1 2 3 4 
 
An 
15 
I am frustrated by being too tired to do the things  
I want to do ............................................................................0 
 
 
 
 
1 
 
2 
 
3 
 
4 
 
An 
16 
I have to limit my social activity because I am tired .............0 
 
 1 2 3 4 
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The Distress Thermometer 
 
Instruct ions:  
First:  Please circle the number (0-10) that best describes how much distress you have been experiencing in 
the past week, including today.  
 
 
Second: Below is a list of common problems for people going through cancer treatment. Please indicate if any 
of the following has been a cause of distress in the past week, including today. Be sure to check YES or NO for 
each.  
 
Yes No Practical Problems  Yes  No  Physical Problems 
  Child care    Appearance 
  Housing    Bathing/dressing 
  Transportation    Breathing 
  Work/School    Changes in urination 
      Constipation 
  Family Problems    Diarrhoea 
  Dealing with children    Eating 
  Dealing with partner    Fatigue 
      Feeling swollen 
  Emotional problems    Fevers 
  Depression    Getting around 
  Fears    Indigestion 
  Sadness    Mouth sores 
  Worry    Nose dry/congested 
      Pain 
  Spiritual / Religious Concerns    Sexual 
  Loss of faith    Skin dry/itchy 
  Relating to God    Sleep 
      Tingling in hands / feet 
 
Other problems: 
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EORTC Quality of Life Questionnaire – QLQ-C30 
 
 
We are interested in some things about you and your health.  Please answer all of the 
questions yourself by circling the number that best applies to you.  There are no “right” or 
“wrong” answers.  The information that you provide will remain strictly confidential. 
 
 
                Not at   A  Quite     Very 
         All Little   a Bit    Much 
1. Do you have any trouble doing strenuous activities, 
 like carrying a heavy shopping bag or a suitcase?  1    2      3       4 
 
2. Do you have any trouble taking a long walk?   1    2      3       4 
 
3. Do you have any trouble taking a short walk outside 
 of the house?       1    2      3       4 
 
4. Do you need to stay in bed or a chair during the day?  1    2      3       4 
 
5. Do you need help with eating, dressing, washing 
 yourself or using the toilet?     1    2      3       4 
 
 
During the past week:             Not at   A  Quite     Very 
         All Little   a Bit    Much 
6. Were you limited in doing either your work or other 
 daily activities?      1    2      3       4 
 
7. Were you limited in pursuing your hobbies or other 
 leisure time activities?     1    2      3       4 
 
8. Were you short of breath?     1    2      3       4 
 
9. Have you had pain?      1    2      3       4 
 
10. Did you need to rest?      1    2      3       4 
 
11. Have you had trouble sleeping?    1    2      3       4 
 
12. Have you felt weak?      1    2      3       4 
 
13. Have you lacked appetite?     1    2      3       4 
 
14. Have you felt nauseated?     1    2      3       4 
 
15. Have you vomited?      1    2      3       4 
 
Please go on to the next page 
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During the past week:      Not at  A  Quite Very 
        All  Little   a Bit  Much 
16. Have you been constipated?     1    2      3   4 
 
17. Have you had diarrhoea?     1    2      3   4 
 
18. Were you tired?      1    2      3   4 
 
19. Did pain interfere with your daily activities?   1    2      3   4 
 
20. Have you had difficulty in concentrating on things, 
 like reading a newspaper or watching television?  1    2      3   4 
 
21. Did you feel tense?      1    2      3   4 
 
22. Did you worry?      1    2      3   4 
 
23. Did you feel irritable?      1    2      3   4 
 
24. Did you feel depressed?     1    2      3   4 
 
25. Have you had difficulty remembering things?  1    2      3   4 
 
26. Has your physical condition or medical treatment 
 interfered with your family life?    1    2      3   4 
 
27. Has your physical condition or medical treatment 
 interfered with your social activities?    1    2      3   4 
 
28. Has your physical condition or medical treatment 
 caused you financial difficulties?    1    2      3   4 
 
 
 
For the following questions please circle the number between 1 and 7 that best 
applies to you. 
 
 
29. How would you rate your overall health during the past week? 
 
 1  2  3  4  5  6  7 
     Very poor                       Excellent 
 
 
30. How would you rate your overall quality of life during the past week? 
 
 1  2  3  4  5  6  7 
     Very poor                       Excellent 
 
 
 
 
 Copyright 1995 EORTC Study Group on Quality of Life. All rights reserved. Version 3.0 
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INTERNATIONAL PHYSICAL ACTIVITY QUESTIONNAIRE 
 
We are interested in finding out about the kinds of physical activities that people do as part of their 
everyday lives. The questions will ask you about the time you spent being physically active in the last 
7 days. Please answer each question even if you do not consider yourself to be an active person. 
Please think about the activities you do at work, as part of your house and yard work, to get from 
place to place, and in your spare time for recreation, exercise or sport. 
 
Think about all the vigorous and moderate activities that you did in the last 7 days. Vigorous 
physical activities refer to activities that take hard physical effort and make you breathe much harder 
than normal. Moderate activities refer to activities that take moderate physical effort and make you 
breathe somewhat harder than normal. 
 
PART 1: JOB-RELATED PHYSICAL ACTIVITY 
 
The first section is about your work. This includes paid jobs, farming, volunteer work, course work, 
and any other unpaid work that you did outside your home. Do not include unpaid work you might do 
around your home, like housework, yard work, general maintenance, and caring for your family. 
These are asked in Part 3. 
 
1. Do you currently have a job or do any unpaid work outside your home? 
 
             Yes 
 
 No Skip to PART 2: TRANSPORTATION 
 
The next questions are about all the physical activity you did in the last 7 days as part of your paid or 
unpaid work. This does not include traveling to and from work. 
 
2.  During the last 7 days, on how many days did you do vigorous physical activities like heavy 
lifting, digging, heavy construction, or climbing up stairs as part of your work? Think about 
only those physical activities that you did for at least 10 minutes at a time. 
 
_____ days per week 
 
 No vigorous job-related physical activity Skip to question 4 
 
3.  How much time did you usually spend on one of those days doing vigorous physical 
activities as part of your work? 
 
_____ hours per day 
_____ minutes per day 
 
4. Again, think about only those physical activities that you did for at least 10 minutes at a time. 
During the last 7 days, on how many days did you do moderate physical activities like 
carrying light loads as part of your work? Please do not include walking. 
_____ days per week 
      
  No moderate job-related physical activity   Skip to question  6 
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5. How much time did you usually spend on one of those days doing moderate physical 
activities as part of your work? 
 
_____ hours per day 
_____ minutes per day 
 
6. During the last 7 days, on how many days did you walk for at least 10 minutes at a time as 
part of your work? Please do not count any walking you did to travel to or from work. 
 
_____ days per week 
 
 No job-related walking Skip to PART 2: TRANSPORTATION 
 
7. How much time did you usually spend on one of those days walking as part of your work? 
 
_____ hours per day 
_____ minutes per day 
 
 
PART 2: TRANSPORTATION PHYSICAL ACTIVITY 
 
These questions are about how you traveled from place to place, including to places like work, 
stores, movies, and so on. 
 
8. During the last 7 days, on how many days did you travel in a motor vehicle like a train, bus, 
car, or tram? 
 
_____ days per week 
 
 No traveling in a motor vehicle Skip to question 10 
 
     9. How much time did you usually spend on one of those days traveling in a train, bus, car, 
tram, or other kind of motor vehicle? 
 
_____ hours per day 
_____ minutes per day 
 
Now think only about the bicycling and walking you might have done to travel to and from work, to 
do errands, or to go from place to place. 
 
10. During the last 7 days, on how many days did you bicycle for at least 10 minutes at a time to 
go from place to place? 
 
_____ days per week 
 
 No bicycling from place to place Skip to question 12 
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11. How much time did you usually spend on one of those days to bicycle from place to place? 
 
_____ hours per day 
_____ minutes per day 
 
12. During the last 7 days, on how many days did you walk for at least 10 minutes at a time to 
go from place to place? 
 
_____ days per week 
 
 No walking from place to place Skip to PART 3: HOUSEWORK, 
HOUSE MAINTENANCE, AND 
CARING FOR FAMILY 
 
13. How much time did you usually spend on one of those days walking from place to place? 
 
_____ hours per day 
_____ minutes per day 
 
 
PART 3: HOUSEWORK, HOUSE MAINTENANCE, AND CARING FOR FAMILY 
 
This section is about some of the physical activities you might have done in the last 7 days in and 
around your home, like housework, gardening, yard work, general maintenance work, and caring for 
your family. 
 
14. Think about only those physical activities that you did for at least 10 minutes at a time. During 
the last 7 days, on how many days did you do vigorous physical activities like heavy lifting, 
chopping wood, shoveling snow, or digging in the garden or yard? 
 
_____ days per week 
 
 No vigorous activity in garden or yard Skip to question 16 
 
 
15. How much time did you usually spend on one of those days doing vigorous physical 
activities in the garden or yard? 
 
_____ hours per day 
_____ minutes per day 
 
16. Again, think about only those physical activities that you did for at least 10 minutes at a time. 
During the last 7 days, on how many days did you do moderate activities like carrying light 
loads, sweeping, washing windows, and raking in the garden or yard? 
 
_____ days per week 
 
 No moderate activity in garden or yard Skip to question 18 
(Appendix 8) WeMICS: Weight Management in Cancer 
Survivors 
PID  - 
Date: -- 
 
Version 2, 10 September 2014         Page 10 of 20 
17. How much time did you usually spend on one of those days doing moderate physical 
activities in the garden or yard? 
 
_____ hours per day 
_____ minutes per day 
 
18. Once again, think about only those physical activities that you did for at least 10 minutes at a 
time. During the last 7 days, on how many days did you do moderate activities like carrying light 
loads, washing windows, scrubbing floors and sweeping inside your home? 
 
_____ days per week 
 
 No moderate activity inside home Skip to PART 4: RECREATION, 
SPORT AND LEISURE-TIME 
PHYSICAL ACTIVITY 
 
19. How much time did you usually spend on one of those days doing moderate physical 
activities inside your home? 
 
_____ hours per day 
_____ minutes per day 
 
 
PART 4: RECREATION, SPORT, AND LEISURE-TIME PHYSICAL ACTIVITY 
 
This section is about all the physical activities that you did in the last 7 days solely for recreation, 
sport, exercise or leisure. Please do not include any activities you have already mentioned. 
 
20. Not counting any walking you have already mentioned, during the last 7 days, on how many 
days did you walk for at least 10 minutes at a time in your leisure time? 
 
_____ days per week 
 
 No walking in leisure time Skip to question 22 
 
21. How much time did you usually spend on one of those days walking in your leisure time? 
 
_____ hours per day 
_____ minutes per day 
 
22. Think about only those physical activities that you did for at least 10 minutes at a time. During 
the last 7 days, on how many days did you do vigorous physical activities like aerobics, running, 
fast bicycling, or fast swimming in your leisure time? 
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_____ days per week 
 
 No vigorous activity in leisure time Skip to question 24 
 
23. How much time did you usually spend on one of those days doing vigorous physical 
activities in your leisure time? 
 
_____ hours per day 
_____ minutes per day 
 
24. Again, think about only those physical activities that you did for at least 10 minutes at a time. 
During the last 7 days, on how many days did you do moderate physical activities like bicycling 
at a regular pace, swimming at a regular pace, and doubles tennis in your leisure time? 
 
_____ days per week 
 
 No moderate activity in leisure time Skip to PART 5: TIME SPENT 
SITTING 
 
25. How much time did you usually spend on one of those days doing moderate physical 
activities in your leisure time? 
_____ hours per day 
_____ minutes per day 
 
 
PART 5: TIME SPENT SITTING 
 
The last questions are about the time you spend sitting while at work, at home, while doing course 
work and during leisure time. This may include time spent sitting at a desk, visiting friends, reading or 
sitting or lying down to watch television. Do not include any time spent sitting in a motor vehicle that 
you have already told me about. 
 
26. During the last 7 days, how much time did you usually spend sitting on a weekday? 
 
_____ hours per day 
_____ minutes per day 
 
27. During the last 7 days, how much time did you usually spend sitting on a weekend day? 
 
_____ hours per day 
_____ minutes per day 
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During the LAST 7 DAYS, how much time did you spent SITTING in the following situations on a 
usual WEEK day and a usual WEEKEND day: (please write your answers in the spaces provided) 
 
 
 WEEK day  WEEKEND day 
 Hours/ 
day 
 Minutes/
day 
 Hours
/day 
 Minutes/
day 
 
a. For TRANSPORT 
(eg in car, bus, train, etc) 
       
 
b. At WORK 
(eg sitting at a desk or using a computer) 
       
 
c. Watching TV 
       
 
d. Using a computer at home 
(eg email, games, information, chatting) 
       
 
e. Other leisure activities 
(eg socialising, movies etc, but 
NOT including TV or computer use) 
       
 
 
 
Source: Marshall AL, Miller YD, Burton NW, Brown WJ. Measuring total and domain-specific sitting: 
a study of reliability and validity. Med Sci Sports Exerc 2010;42(6):1094–1102. 
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SUB-STUDY OF THE PREVIEW STUDY AUSTRALIA: 
Effects of weight loss on appetite, bone mass and muscle strength 
 
Visual Analogue Questionnaires (please copy double sided) 
 
 
Participant number:                             Date given:  DD/MM/YYYY 
 
 
 Please complete the following two identical questionnaires in the morning. 
 
 The first questionnaire is to be completed after getting up and before preparing breakfast. You 
will need to have fasted for at least 8 hours (no food or drink other than water) before doing 
the first questionnaire. 
 
 The second questionnaire is to be completed after you have eaten that same breakfast meal.  
 
 Please write the time you start each questionnaire in the space provided, and then answer each 
of the questions by placing a vertical mark (          ) at the appropriate point on the line 
corresponding to how you are feeling at this moment. 
 
 
Example: 
 
                                                   How TIRED do you feel now? 
 
 
 
 
 
 
 Further LEFT means you do not feel the sensation in question. 
 Further RIGHT means you feel in very much. 
 Please mark all scales. 
 Please bring these pages with you the next time you come to see us.  
 Thank you very much for your help.  
  
Not at all Extremely 
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This page has been left deliberately blank. 
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SUB-STUDY OF THE PREVIEW STUDY AUSTRALIA: 
Effects of weight loss on appetite, bone mass and muscle strength 
 
 
Visual Analogue Questionnaire 1 (before breakfast) 
 
 
Participant number:                             Date:  DD/MM/YYYY Time: …………..... 
 
 
                                             How HUNGRY do you feel now? 
      
 
 
 
                                How FULL do you feel now?     
 
 
 
                                         
                                How strong is your DESIRE TO EAT?  
     
 
 
 
                                                      How MUCH food could you EAT now?    
  
 
 
                                            
                                                     How NAUSEOUS do you feel now? 
 
 
 
                                                        
                                                              How IRRITABLE do you feel now? 
 
  
    
 
                                                    How BLOATED do you feel?  
     
 
 
 
                                 How ALERT do you feel?      
 
 
 
 
 
After completing Questionnaire 1, please eat breakfast and then turn the page to complete Questionnaire 2…
Not at all Extremely 
Not at all Extremely 
Not at all Extremely 
None at all A large amount 
Not at all Extremely 
Not at all Extremely 
Not at all Extremely 
Not at all Extremely 
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SUB-STUDY OF THE PREVIEW STUDY AUSTRALIA: 
Effects of weight loss on appetite, bone mass and muscle strength 
 
 
Visual Analogue Questionnaire 2 (after breakfast) 
 
 
Time: ………….. 
 
                                             
                                             How HUNGRY do you feel now? 
      
 
 
 
                                How FULL do you feel now?     
 
 
 
                                         
                                How strong is your DESIRE TO EAT?  
     
 
 
 
                                                      How MUCH food could you EAT now?    
  
 
 
                                            
                                                     How NAUSEOUS do you feel now? 
 
 
 
                                                        
                                                              How IRRITABLE do you feel now? 
 
  
    
 
                                                    How BLOATED do you feel?  
     
 
 
 
                                 How ALERT do you feel?      
 
 
 
 
 
What did you have for breakfast? ………………………………………………………………..………… 
…………………………………………………………………………………………………………… 
 
Not at all Extremely 
Not at all Extremely 
Not at all Extremely 
None at all A Large amount 
Not at all Extremely 
Not at all Extremely 
Not at all Extremely 
Not at all Extremely 
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3-day Weighed Food Diary 
 
Name:_________________________ 
Instructions: 
1. Keep food record for 3 days (please include 2 weekdays and 1 weekend day)  
e.g. Thurs, Fri and Sat or Sun, Mon and Tue 
2. Please weigh all foods AND measure amount of liquid you have (including type or brand 
name of the food product)  
3. Please specify if you have had take away food/or eating out. If not enough room/space, please attach an 
extra piece of paper. 
 
Example:  
Date: xx/xx/2013    Day of week: Thursday      Working: Y/N 
  Food items 
 
Extras (snacks/ 
physical/ activities/ 
feelings) 
Breakfast: nil 
(Time:           -     ) 
Woke up at 9.30am 
1 glass of water (250ml) 
Feeling tired and 
nauseated  
Morning Tea 
(Time: 10.00am  ) 
 
1 cup of coffee (200ml) + 1 tsp sugar (4g) + 30ml regular 
milk 
2 plain biscuits (McVities Digestive Milk Chocolate 
biscuit,17.3g each biscuit)  
Ready to go to work, 
feeling better 
Lunch 
(Time: 2pm          ) 
 
1 toasted sandwich (1 slice of ham, 10g + 2 slices 
cucumber, 20g, ) 
+ 500ml orange juice from juice bar 
 
Afternoon Tea 
(Time: 5pm   ) 
 
1 banana,150g and 250ml water  
Dinner 
(Time:    8pm  ) 
 
Chinese take away: fried rice (400g) 
+ 250ml apple juice  – homemade fresh  
Finished work at 
10pm 
Supper 
(Time:  12am      ) 1 Lindt Chocolate bar, 30g 1am bed time 
 
Total amount of juice/ cordial/ soft drinks: 750ml juice/ Lemonade 1 can per day 
Total amount of alcohol per day: None 
Total amount of coffee/tea: 1 coffee/d 
Any craving : craving for sweet things at night  
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DAY 1   Date: _______________Day of week: ________________ Working:Y/ N 
 Food items 
 
Extras  
(snacks/ physical 
activities/feelings) 
Breakfast: 
 
(Time:                ) 
 
 
 
 
 
 
 
 
Morning Tea 
 
(Time:                ) 
 
  
Lunch 
 
(Time:               ) 
 
 
 
 
  
Afternoon Tea 
 
(Time:              ) 
 
  
Dinner 
 
(Time:                ) 
 
 
 
 
 
  
Supper 
 
(Time:                ) 
 
  
 
Total amount of juice/ cordial/ soft drinks per day: _________________________ 
Total amount of alcohol per day: ______________________________ 
Total amount of coffee/tea per day ____________________________________ 
Any craving? ____________________________________________________
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DAY 2   Date: _______________ Day of week: ____________  Working: Y/ N 
 
 Food items 
 
Extras  
(snacks/ physical 
activities/feelings) 
Breakfast: 
 
(Time:                ) 
 
 
 
 
 
 
 
 
 
Morning Tea 
 
(Time:                ) 
 
  
Lunch 
 
(Time:               ) 
 
 
 
 
 
  
Afternoon Tea 
 
(Time:              ) 
 
  
Dinner 
 
(Time:                ) 
 
 
 
 
 
  
Supper 
 
(Time:                ) 
 
  
 
Total amount of juice/ cordial/ soft drinks per day: _________________________ 
 
Total amount of alcohol/coffee/tea per day: ______________________________ 
 
Any craving? ____________________________________________________ 
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DAY 3  Date: _______________ Day: _________________Working: Y/ N 
 
 Food items 
 
Extras  
(snacks/ physical 
activities/feelings) 
Breakfast: 
 
(Time:                ) 
 
 
 
 
 
 
 
 
 
Morning Tea 
 
(Time:                ) 
 
  
Lunch 
 
(Time:               ) 
 
 
 
 
 
  
Afternoon Tea 
 
(Time:              ) 
 
  
Dinner 
 
(Time:                ) 
 
 
 
 
 
  
Supper 
 
(Time:                ) 
 
  
 
Total amount of juice/ cordial/ soft drinks per day: _________________________ 
 
Total amount of alcohol/coffee/tea per day: ______________________________ 
 
Any craving? ______________________________ 
 
 
 
 
 
This is the end of the questionnaire, thank you for participating. 
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Activity monitor instructions 
As this is a scientific research study it is important that you follow these instructions carefully. 
 It is very important that you wear the activity monitor ALL DAY, EVERYDAY for the specified 7 
day period. If you forget to wear it for a while, please DO wear it for the remainder of the 7 days. 
 You do not need to wear the activity monitor to bed at night. Instead take it off and put it 
somewhere, where you will be reminded to put it on again as soon as you wake up in the morning. The 
bedside table is a good place to put the monitor while you sleep. 
 Please, do not shake it when you are not wearing it. 
 Please take the monitor OFF when showering, bathing or swimming and put it back on 
afterwards. The activity monitor is weatherproof but not waterproof – please. 
 Please handle the activity monitor carefully – try not to drop it, and please do not try to take it apart. 
How to wear the activity monitor 
 It is important that you wear the activity monitor on an elastic belt on the right side of your waist; 
check the pictures below for the correct placement.  
 Also check the label on the activity monitor to see which side should be worn up. The monitor 
should sit straight like in the picture. It is important that the activity monitor fits you snugly because 
it will not record your activities accurately if it is loose. You can wear the activity monitor underneath 
your shirt. 
  
 Please do not worry about any blinking lights or the absence of a light. This will not 
tell you if the activity monitor is working or not. You do not need to record anything from 
the activity monitor as it stores all the information we need. When we receive the activity 
monitor back from you, it will be connected to a computer to download the information. 
If you have any questions do not hesitate to contact a member of the Team on 
9767 6836    
 START DATE:          STOP DATE: 
GUIDELINE 3: 
Limit intake of foods containing saturated fat, added  
salt, added sugars and alcohol.
a. Limit intake of foods high in saturated fat such as 
many biscuits, cakes, pastries, pies, processed 
meats, commercial burgers, pizza, fried foods,  
potato chips, crisps and other savoury snacks. 
•	 Replace	high	fat	foods	which	contain	
predominately saturated fats such as butter,  
cream, cooking margarine, coconut and palm 
oil	with	foods	which	contain	predominately	
polyunsaturated and monounsaturated fats such  
as oils, spreads, nut butters/pastes and avocado. 
b.  Limit intake of foods and drinks containing  
added salt. 
•	 Read	labels	to	choose	lower	sodium	options	
among similar foods. 
•	 Do	not	add	salt	to	foods	in	cooking	or	at	 
the table.
c. Limit intake of foods and drinks containing added 
sugars	such	as	confectionery,	sugar-sweetened	 
soft drinks and cordials, fruit drinks, vitamin  
waters,	energy	and	sports	drinks.
d.	 If	you	choose	to	drink	alcohol,	limit	intake.	For	women	
who	are	pregnant,	planning	a	pregnancy	or	
breastfeeding, not drinking alcohol is the safest option.
GUIDELINE 4: 
Encourage, support and promote breastfeeding.
GUIDELINE 5: 
Care for your food; prepare and store it safely.
WHAT ARE THE DIETARY GUIDELINES?
The Australian Dietary Guidelines provide 
up-to-date advice about the amount and 
kinds of foods that we need to eat for 
health and wellbeing. They are based  
on scientific evidence and research.
The Australian Dietary Guidelines of most 
relevance to adults are included below:
GUIDELINE 1: 
To	achieve	and	maintain	a	healthy	weight,	be	
physically active and choose amounts of nutritious 
food and drinks to meet your energy needs.
•	 Older people should eat nutritious foods and keep 
physically active to help maintain muscle strength 
and	a	healthy	weight.
GUIDELINE 2:
Enjoy	a	wide	variety	of	nutritious	foods	from	these	five	
food groups every day:
•	 Plenty of vegetables of different types and colours, 
and legumes/beans
•	 Fruit
•	 Grain	(cereal)	foods,	mostly	wholegrain	and/or	high	
cereal	fibre	varieties,	such	as	breads,	cereals,	rice,	
pasta, noodles, polenta, couscous, oats, quinoa  
and barley
•	 Lean	meats	and	poultry,	fish,	eggs,	tofu,	nuts	and	
seeds, and legumes/beans
•	 Milk, yoghurt, cheese and/or their alternatives, 
mostly reduced fat
And	drink	plenty	of	water.
Want more information about healthy eating? 
FOODS TO LIMIT: DISCRETIONARY CHOICES
‘Discretionary choices’ are called that because they 
are not an essential or necessary part of our dietary 
patterns. Discretionary foods are high in kilojoules, 
saturated fat, added sugars, added salt or alcohol. 
If chosen, they should be eaten only sometimes 
and in small amounts.
Examples of discretionary choices include:
•	 Sweet biscuits, cakes and desserts 
•	 Processed meats and sausages
•	 Ice-cream, confectionery and chocolate
•	 Meat pies and other pastries
•	 Commercial burgers, hot chips,  
and fried foods
•	 Crisps and other fatty and/or salty snacks
•	 Cream and butter 
•	 Sugar-sweetened cordials, soft drinks,  
fruit drinks and sports drinks
•	 Alcoholic drinks
The Australian Dietary Guidelines provide  
up-to-date advice about the amount and  
kinds of foods that we need to eat for health  
and wellbeing.
For more information visit:
www.eatforhealth.gov.au
or contact:
National Health and Medical Research Council
GPO Box 1421
Canberra ACT 2601 
13 000 NHMRC (13 000 64672)
To order print copies contact:
National Mailing and Marketing
Email: health@nationalmailing.com.au
Phone: 02 6269 1080
Publication Reference: N55g
 
TIPS FOR CHOOSING NUTRITIOUS  
FOODS AND DRINKS
Eating for health and wellbeing is about choosing 
foods from the Five Food Groups every day, while 
limiting foods that are not essential to our health.
•	Plan ahead and stock up on basic nutritious 
foods like wholegrain cereals and other grain 
foods, reduced fat milk, lentils or other legumes, 
eggs, and frozen or canned foods without added 
sugars or added salt – this way you can eat at 
home more often and cook meals yourself by 
adding fresh ingredients.
•	Choose a variety of types and colours of fresh 
vegetables and fruits that are in season.
•	Try new ways of cooking with vegetables like 
roasting, baking, barbequing and stir-frying.  
Add extra vegetables and legumes to your recipes.
•	Use fruit for snacks and desserts.
•	Lean red meats are important, but a maximum  
of 455g a week is recommended.
•	Include at least 1 or 2 meat-free meals each week 
– include eggs, legumes such as beans and tofu, 
and nuts and seeds.
•	Choose reduced-fat varieties of milk, yoghurt  
and cheese. 
•	Include small amounts of foods rich in unsaturated 
fats such as oils, spreads, nut butters/pastes  
and avocado.
•	Drink plenty of water instead of drinks with  
added sugars or alcohol. 
•	Choose carefully when eating out- limit creamy, 
commercially baked or fried foods.
•	Store unused cooked food in the fridge.
•	Older people who have trouble with their teeth, 
may prefer softer textured or cooked vegetables 
and fruit, finely milled wholegrain cereal foods 
and dishes like soups, casseroles or stews.
Healthy
adults
eating for
EAT FOR HEALTH AND WELLBEING
1 
medium
Vegetables and legumes/beans
Fruit
Grain (cereal) foods, mostly wholegrain and/or 
high cereal fibre varieties
Milk, yoghurt, cheese and/or alternatives,  
mostly reduced fat
Lean meat and poultry, fish, eggs, tofu, nuts and  
seeds, and legumes/beans
19–50 
years
51–70 
years
70+ 
years
Men 6 5½ 5
Women 5 5 5
Serves per day
A standard serve of vegetables is about 75g (100-350kJ) or:
½ cup cooked green or orange vegetables (for example, broccoli,  
spinach, carrots or pumpkin)
½ cup cooked, dried or canned beans, peas or lentils*
1 cup green leafy or raw salad vegetables
½ cup sweet corn
½ medium potato or other starchy vegetables (sweet potato,  
taro or cassava)
1 medium tomato
A standard serve of fruit is about 150g (350kJ) or:
1 medium apple, banana, orange or pear
2 small apricots, kiwi fruits or plums
1 cup diced or canned fruit (with no added sugar)
 Or only occasionally:
125ml (½ cup) fruit juice (with no added sugar)
30g dried fruit (for example, 4 dried apricot halves,  
1½ tablespoons of sultanas)
A standard serve (500kJ) is:
1 slice (40g) bread
½ medium (40g) roll or flat bread
½ cup (75–120g) cooked rice, pasta, noodles, barley, buckwheat, semolina, 
polenta, bulgur or quinoa 
½ cup (120g) cooked porridge
²/³ cup (30g) wheat cereal flakes 
¼ cup (30g) muesli
3 (35g) crispbreads
1 (60g) crumpet
1 small (35g) English muffin or scone
A standard serve (500-600kJ) is:
65g cooked lean meats such as beef, lamb, veal, pork, goat or  
kangaroo (about 90–100g raw)* 
80g cooked lean poultry such as chicken or turkey (100g raw)
100g cooked fish fillet (about 115g raw weight) or one small can of fish
2 large (120g) eggs
1 cup (150g) cooked or canned legumes/beans such as lentils, chick peas or 
split peas (preferably with no added salt)
170g tofu
30g nuts, seeds, peanut or almond butter or tahini or other nut or 
seed paste (no added salt)
A standard serve (500-600kJ) is:
1 cup (250ml) fresh, UHT long life, reconstituted powdered milk or buttermilk 
½ cup (120ml) evaporated milk
2 slices (40g) or 4 x 3 x 2cm cube (40g) of hard cheese, such as cheddar
½ cup (120g) ricotta cheese
¾ cup (200g) yoghurt
1 cup (250ml) soy, rice or other cereal drink with at least 100mg of added  
calcium per 100ml
*weekly limit of 455g
HOW MUCH IS A SERVE?
It’s	helpful	to	get	to	know	the	recommended	serving	sizes	
and serves per day so that you eat and drink the right amount 
of	the	nutritious	foods	you	need	for	health	–	as	shown	in	the	
tables above. We’ve given you the serve size in grams too, so 
you	can	weigh	foods	to	get	an	idea	of	what	a	serve	looks	like.	
The ‘serve size’ is a set amount that doesn’t change. It is 
used	along	with	the	‘serves	per	day’,	to	work	out	the	total	
amount of food required from each of the Five Food Groups. 
‘Portion	size’	is	the	amount	you	actually	eat	and	this	will	
depend	on	what	your	energy	needs	are.	Some	people’s	
portion sizes are smaller than the ‘serve size’ and some are 
larger. This means some people may need to eat from the 
Five Food Groups more often than others.
HOW MANY SERVES A DAY?
Few	people	eat	exactly	the	same	way	each	day	and	it	is	
common to have a little more on some days than others. 
However,	on	average,	the	total	of	your	portion	sizes	should	end	
up being similar to the number of serves you need each day.
If	you	eat	portions	that	are	smaller	than	the	‘serve	size’	you	will	
need to eat from the Food Groups more often. If your portion 
size	is	larger	than	the	‘serve	size’,	then	you	will	need	to	eat	 
from the Food Groups less often.
19–50 
years
51–70 
years
70+ 
years
Men 2 2 2
Women 2 2 2
Serves per day
19–50 
years
51–70 
years
70+ 
years
Men 6 6 4½
Women 6 4 3
Serves per day
19–50 
years
51–70 
years
70+ 
years
Men 3 2½ 2½
Women 2½ 2 2
Serves per day
19–50 
years
51–70 
years
70+ 
years
Men 2½ 2½ 3½
Women 2½ 4 4
Serves per day
1  
slice
 
cup
² ³
The Australian Dietary Guidelines provide up-to-date 
advice about the amount and kinds of foods and drinks 
that	we	need	regularly,	for	health	and	well-being.	
By eating the recommended amounts from the Five 
Food Groups and limiting the foods that are high in 
saturated fat, added sugars and added salt, you get 
enough of the nutrients essential for good health.  
You may reduce your risk of chronic diseases such 
as heart disease, type 2 diabetes, obesity and some 
cancers. You may also feel better, look better, enjoy  
life more and live longer!
The	amount	of	food	you	will	need	from	the	Five	Food	
Groups	depends	on	your	age,	gender,	height,	weight	
and	physical	activity	levels,	and	also	whether	you	are	
pregnant	or	breastfeeding.	For	example,	a	43-year-
old man should aim for 6 serves of vegetables a day, 
whereas	a	43-year-old	woman	should	aim	for	5	serves	 
a day. A 61-year-old man should aim for 6 serves of 
grain	(cereal)	foods	a	day,	and	a	61-year-old	woman	
should	aim	for	4	serves	a	day.	Those	who	are	taller	 
or	more	physically	active	(and	not	overweight	or	
obese) may be able to have additional serves of the 
Five Food Groups or unsaturated spreads and oils  
or discretionary choices.
For	further	information	go	to	www.eatforhealth.gov.au.
½ 
medium
1 
cup
½  
cup
½  
cup
65g 80g 100g 2 large
1 
cup
2  
slices
1 
cup
¾
cup
1 
cup
FOR FURTHER INFORMATION GO TO  www.eatforhealth.gov.au
*preferably with no added salt
Which foods should I eat and How much?
 
 
   To meet additional energy needs, extra serves 
from the Five Food Groups or unsaturated 
spreads and oils, or discretionary choices 
may be needed only by those adults who are 
taller or more active, but not overweight.
 
 
   An allowance for unsaturated spreads and oils 
for cooking, or nuts and seeds can be included 
in the following quantities: 28-40g per day for 
men less than 70 years of age, and 14-20g per 
day for women and older men.
 
 
   For meal ideas and advice on how to 
apply the serve sizes go to:
www.eatforhealth.gov.au
SERVE SIZES
1 
cup
2 
small
½ cup
cooked
½ cup
cooked
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          Patient Initials:        Date of birth:                                         Study ID: 
        - -                      .   .                                     
                (First- Middle-Last)        (dd/mm/yyyy) 
Adverse Event Reporting Form: S 
 
    Indicate X where applicable; N/A  
EVENT DETAILS 
1. Date of event:  
 
____ ____ / ____ ____ /____ ____   (dd/mm/yy) 
 
2. Date made known to investigator: 
 
____ ____ / ____ ____ /____ ____   (dd/mm/yy) 
 
3. Description of event: 
 
 ________________________________________________ 
 
________________________________________________ 
 
________________________________________________ 
 
 
 
 
________________________________________________ 
 
________________________________________________ 
 
________________________________________________ 
 
4. Definition of event (select all that apply): 
  Fatal                   Life-threatening  
  Persistent or significant disability / incapacity 
  Hospitalisation   Prolongation of hospitalisation  
      (please obtain copies of any discharge reports relating to the event) 
 
  Other, specify: _______________________________ 
 
5. Did the event occur during protocol treatment? 
  No      Yes, during supervised PA session  
  Yes, during fitness testing 
  Yes, during unsupervised fitness session 
 
 
6. Was any treatment given for the event? 
  No   Yes, specify: 
 
Type:        ________________________________________ 
 
Outcome: ________________________________________ 
 
7.  Did the participant need to access any health care providers 
due to the event? (eg general practitioner, physiotherapist ) 
  No   Yes, specify (who + frequency of contact): 
 
__________________________________________________ 
 
__________________________________________________ 
 
7. Did the patient have any relevant concurrent non-
malignant disease at the time of the event? 
  No   Yes, specify: 
 
________________________________________________ 
 
 
8. Assessment of relation of event to study protocol: 
 
________________________________________________ 
 
________________________________________________ 
 
 
CTAE GRADING  
CTAE Name:  (refer to NCI 
CTAE V3.0)  
Date of onset: 
__ __ / __ __ /__ __   
(dd/mm/yy) Date of resolution: 
__ __ / __ __ /__ __     
(dd/mm/yy) 
Grade:   (1-5) 
Relation to PA program:   N/A   Unrelated   Unlikely   Possible   Probable  Definite 
Relation to Fitness Testing:   Unrelated   Unlikely   Possible   Probable  Definite 
Change required to protocol 
therapy:   None   Regime reduced   Regime interrupted   Regime discontinued 
Outcome of AE:   Recovered   Event ongoing   Recovered w. sequelae   Died of event 
  
 
Investigator name:  _____________________________         Signature: ___________________________________                   
        
Date:  ____ ____ / ____ ____ /____ ____   (dd/mm/yy) 
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Thank you for your feedback. This will help us to improve our program. 
 
Version 2, Dated 2 March 2015 
Participant ID:    Date: 
These questions are about your experience of attending the Weight Management Program. Please 
indicate how strongly you agree or disagree by ticking one answer on each line. 
 Strongly 
Agree 
(1) 
Agree 
 
(2) 
Unsure 
 
(3) 
Disagree 
 
(4) 
Strongly 
Disagree 
(5) 
1. I intend to tell other people about the 
program. 
     
2. I feel it was worth my time and effort to take 
part in the program. 
     
3. The program has helped me set goals that are 
reasonable and within reach. 
     
4. I trust the information and advice I was given 
in the program. 
     
5. Program leaders were well organised. 
 
     
6. I felt confident that the Dietitian was 
knowledgeable. 
     
7. I felt confident that the Dietitian was capable. 
 
     
8. I felt confident that the Exercise Physiologist 
was knowledgeable. 
     
9. I felt confident that the Exercise Physiologist 
was capable. 
     
10. The program was enjoyable. 
 
     
 
 What was the most enjoyable aspect of the program? 
_____________________________________________________________________________________
_____________________________________________________________________________________ 
What was the least enjoyable aspect of the program? 
_____________________________________________________________________________________
_____________________________________________________________________________________ 
Do you have any suggestions or recommendations for improving the program? 
_____________________________________________________________________________________
_____________________________________________________________________________________     
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Semi-Structured Interview Question Guide 
 
For all participants: 
 
1. How did you find weight management clinic? 
a. What worked well for you? 
b. What didn’t work well for you? 
 
2. At the start of the program what were your goals? 
a. Dietary focus? 
b. Exercise focus? 
c. Did you achieve your goals? 
d. How do you feel about that? 
 
3. Did your physical activity levels change during the program? 
a. Are you doing more/less than the start?  
i. If more, how are you achieving this? What do you think will help sustain these 
changes? 
iii.   If less, what has made it hard for you to be active? 
 
4. Did your diet change during the program? 
a. If yes, how did it change? 
b.  How do you feel about these changes? 
c. What do you think will help sustain these changes? 
 
5. Services 
a. Are you using any other services, such as allied health, palliative care, home care or 
alternative therapies? 
b. If yes, what prompted you to access these? 
c. If no, why not?  Are there any barriers to accessing other services? 
 
6. Experience of recovery from treatment 
a. How have you been feeling? 
b. Was this what you were expecting to happen and how you would feel? 
c. Has this been better or worse than you expected? 
d. What do you think/feel has made things better or worse? 
 
7. Functional ability 
a. How independent do you feel at the moment? 
b. Is this how you expected things would be at this time? 
c. What do you think/feel has made a difference to this? 
 
8. Emotional impacts 
a. At this time, what are the main concerns for you in dealing with the diagnosis of your 
cancer? 
b. What do you think will help with this? 
 
9. What are the best things about the weight management program? 
 
10. What is the worst thing about the weight management program? 
 
11. What has been the most important part of the program for you? 
 
12. What has been the least important part of the program for you? 
 
13. Do you have any suggestions about how the program could be improved? 
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14. Would you recommend the program to others? 
 
